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1.1 Brain 
Humans (and animals) are able to learn (remembering events or skills) and to 
forget. This ability of the brain has been a subject of interest for neuroscientists, 
psychologists and philosophers for many decades. Already 387 B.C. Plato 
describes that the brain is the seat of the mental process. In 1664 Thomas Willis 
publishes Cerebri anatome (in Latin) and in 1681 he coins the term Neurology. 
With the use of a silvernitrate staining method developed by Camillo Golgi in 
1873, Santiago Ramon y Cajal described that neurons are independent 
elements. He proposed that memories might be formed by strengthening the 
connections between existing neurons to improve the effectiveness of their 
communication. Both Camillo Golgi and Santiago Ramon y Cajal received a 
Nobel prize in 1906 for their contribution to the field. 
 
1.1.1 Gross anatomy 
The human nervous system can anatomically be divided into the peripheral 
nervous system (PNS) and the central nervous system (CNS). The PNS is the 
information source of the CNS and can be divided into a somatic and  an 
autonomic part. The somatic PNS is associated with voluntary control of body 
movement and consist of 12 pairs of cranial nerves and 31 pairs of spinal 
nerves. These sensory and motor neurons innervate the skin, muscles and 
joints. The cell bodies of these neurons lie in the dorsal root ganglia and the 
cranial ganglia. Receptors associated with dorsal root and cranial ganglion 
cells provide sensory information to the CNS about muscle and limb positions 
and about touch and pressure at the body surface. The autonomic division of 
the PNS mediates sensation and motor control of the viscera, smooth muscles 
and exocrine glands. It consists of the sympathetic (response to stress), 
parasympathetic (restore homeostasis) and enteric system (smooth muscles 
of the gut). 
The CNS can anatomically be divided into the spinal cord, medulla 
oblongata, pons, midbrain, cerebellum, diencephalon and the cerebral 
hemispheres (figure 1). The spinal cord is the most caudal part of the CNS. It 
receives sensory information from the skin, joints and muscles and contains 
motor neurons responsible for movement (voluntary and reflex). Rostral to the 
spinal cord lies the brain stem, containing the medulla oblongata, pons and 
midbrain. The brainstem is involved in the regulation of blood pressure and 
respiration, sensations (e.g. taste, hearing, vision), balance, movement, sleep 
and control of the facial and neck muscles. 
The cerebellum contains the highest number of neurons in the CNS. Partly 
because the types of neurons in the cerebellum are limited, its circuitry is well 
understood. It receives somatosensory input from the spinal cord, motor 
information from the cerebral cortex, and input about balance from the 
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vestibular organs of the inner ear. The cerebellum is important for maintaining 
posture and for coordinating head and eye movement, in fine tuning of the 
muscle movement and for learning motor skills. The cerebellum is also 
involved in language and other cognitive functions. 
 
 
 
The diencephalon is formed by the thalamus and hypothalamus. The 
thalamus plays a gating and modulation role in relaying sensory information 
to the neocortex. The thalamus is also involved in modulating information from 
the cerebellum and basal ganglia to the cerebral cortex and is thought to 
influence levels of attention and consciousness. The hypothalamus regulates 
hormonal secretion of the pituitary gland and thus is essential for homeostasis 
and reproduction. The hypothalamus is also a component of the motivation 
system of the brain and regulates circadian rhythms. 
The largest part of the brain is formed by the cerebral hemispheres. These 
consist of the cerebral cortex, basal ganglia, amygdala and hippocampus. 
Within these structures lie our perceptual, motor and cognitive functions, 
including memory, emotion, social behavior and fine movement. 
 
1.1.2 Neurons 
In 1836 Gabriel Gustav Valentin was the first anatomist to describe a neuron. 
Years later, in 1891 Wilhem von Waldeyer first introduces the term neuron. A 
neuron, like cells in all tissues, has a cell body with a nucleus and other 
subcellular components that synthesize proteins. In addition, neurons contain 
an axon, the function of which is to conduct signals away from the cell body 
(soma), and dendrites that conduct signals toward the cell body. Dendrites 
are extensively arborized to enlarge the surface area onto which they receive 
afferent input from axons of other neurons. 
Over 50 distinct types of neurons have been described (figure 2). Apart from 
two limited regions in the adult brain (the subventricular zone and the inner 
Figure 1 Sagital midsection of a 
human brain. 
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blade of the dentate gyrus) neurons no longer divide. This indicates that 
unlike e.g. liver cells, one neuron cannot simply be replaced by another. 
 
 
 
 
 
One of the great things of neurons is that they can communicate with each 
other using electrical or chemical signals. The structure where this 
communication between neurons takes place is called synapse. Here the 
membrane contains specialized proteins, like ion channels and receptors, 
permitting influx and efflux of inorganic ions. 
 
1.1.3 Neuroglial cells 
Supporting cells in the CNS are the neuroglial cells, also called glial cells or 
glia, that outnumber the number of neurons. The functions of glial cells 
include maintainance of the ionic milieu of nerve cells, modulation of the rate 
of nerve signal propagation, modulation of  synaptic transmission by 
controlling the uptake of neurotransmitters, providing a scaffold for some 
aspects of neural development, formation of the blood brain barrier. Glial 
cells also aid in recovering from neural injury.  
Three types of glial cells are described in the CNS: astrocytes, 
oligodendrocytes and microglial cells. A number of morphological distinct 
types of astrocytes can be found in the CNS. These include protoplasmic 
astrocytes in the gray matter, fibrous astrocytes in the white matter, radial glia 
in the cerebellum and sub-ependymal astrocytes adjacent to the cerebral 
ventricles (Eng et al., 2000). As a result of trauma, neurodegenerative 
disorders or neurotoxicity astrocytes in the CNS proliferate and become 
hypertrophic. This process is called astrogliosis (Cotrina and Nedergaard, 
2002; Eddleston and Mucke, 1993; Eliasson et al., 1999; Eng and Ghirnikar, 
1994; Rutka et al., 1997). 
gure 2 Golgi staining of (A) Hippocampal CA1 pyramidal neuron, 
with dendrites, cell body and axon. (B) Cerebellar Purkinje cell with 
endritic tree, a cell body and axon. (C) Enlargement of the 
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Oligodendrocytes in the CNS, like Schwann cells in the PNS, form a myelin 
sheet around some axons. This myelin sheet electrically insulates the axons 
and so markedly increases the speed of electrical signal transmission. 
Microglial cells are derived primarily form hematopoietic precursor cells. They 
share many properties with macrophages found in other tissues, and are 
primarily scavenger cells that remove cellular debris from sites of injury or 
normal cell turnover. In addition, they secrete signaling molecules that can 
modulate local inflammation and influence cell survival or death. Similar to 
astrocytes, the number of microglia following brain damage at the site of 
injury increases. 
 
1.2 Neuronal Development 
The development of human and other species starts with the fusion of the 
oocyte and sperm, the zygote is born. After approximately eight days two 
primitive cell layers (germ layers) are formed: the primary ectoderm and 
primary endoderm. At day 16 the primitive streak, is formed. The primitive 
streak evolves into a primitive groove, pit and node. The future head will be 
formed near the primitive pit, and the cranial/caudal, left/right, and 
ventral/dorsal axes of the body are established. From this primitive streak 
flattened cells migrate into the space between the primary ectoderm and 
primary endoderm forming the third primitive cell layer, the mesoderm. These 
flattened cells also migrate to the primary endoderm to replace cells and 
form the definitive endoderm, or entoderm. This process is called gastrulation. 
One key consequence of gastrulation is the formation of the notochord within 
the mesoderm. The ectoderm that lies immediately above the notochord, is 
called the neuroectoderm. The neuroectoderm will give rise to the entire 
nervous system. 
The notochord signals the neuroectodermal cells to differentiate into neuronal 
precursor cells and so form the neural plate. The neuronal plate folds inward 
to form the neural tube, a structure that will give rise to the brain and spinal 
cord. Thickenings in the neural tube at the rostral end are formed that are the 
forerunners of the major brain regions. These thickenings are called the 
prosencephalon (forebrain), mesenchephalon (midbrain), rhombencephalon 
(hindbrain) and spinal cord. The prosencephalon will be divided in the 
telencephalon (eventually forming the cerebral cortex, hippocampus and 
basal ganglia) and the diencephalon (forming the thalamus and 
hypothalamus). The mesencephalon will form the superior and inferior colliculi 
whereas the rhombencephalon will be divided into the metencephalon 
(forming the cerebellum and pons) and the myelencephalon (forming the 
medulla). 
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During development, synaptic connections between neurons have to be 
made between the appropriate pre- and postsynaptic neuron. In fact, it is 
remarkable that axons are able to find the way to their appropriate synaptic 
partner, sometimes over many centimeters. Axons find their way to their 
postsynaptic neuron through a complex mechanism involving attractive and 
repulsive signaling molecules. The growth cone at the tip of the axon detects 
and responds to such signaling molecules. The growth cone is a sheetlike 
expansion of the growing axon at its tip, called a lamellipodium. Numerous 
fine processes called filopodia rapidly form and disappear from the 
lamellipodium. Growth cones are highly motile, which is mediated by rapid, 
controlled rearrangement of cytoskeletal elements. 
 
1.3 Neuronal Plasticity 
The nervous system can change in response to a variety of intrinsic or extrinsic 
inputs. This adaptation is called neuronal plasticity; the flexibility of neurons to 
change their neuronal network. Neuronal plasticity is obvious during the 
development of neural circuits. However, the adult brain must also be able to 
adapt to changes in the external environment e.g. to learn new skills and 
establish new memories. Novel information is presumed to be stored within 
neuronal networks. One obvious place to change neuronal network 
properties is at the site of communication between two neurons, the synapse. 
Changes in the strength of communication between neurons is therefore 
called synaptic plasticity. Two cellular models of synaptic plasticity have been 
described: long-term potentiation (LTP) and long-term depression (LTD) 
resulting in increases and decreases in synaptic strength respectively. LTP and 
LTD have extensively been studied as cellular models for learning and 
memory formation. 
 
1.3.1 LTP and LTD 
LTP and LTD can be induced in different ways and depend on the 
developmental state and the brain area. In the hippocampus, both LTP and 
LTD depend on the NMDA-receptor, which is a specific type of glutamate 
receptor. In the hippocampus LTP can be induced by a variety of protocols, 
which result in de activation of the NMDA receptor, resulting in an influx of 
Ca2+. This elevation of the internal Ca2+ concentration is necessary for the 
induction of LTP. LTP can be divided into an early phase and a late phase 
(Malenka and Bear, 2004; Massey and Bashir, 2007). The early phase of LTP, 
lasting 1 to 3 hours, does not depend on protein synthesis, while the late 
phase, lasting at least 24 hours, of LTP requires de novo RNA and protein 
synthesis. One of the proteins that is upregulated after LTP in the 
hippocampus is Synaptopodin (Chapter 4). 
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1.4 Cytoskeleton 
Cells are dynamic, they grow, divide and change shape. These dynamics 
requires cells to be able to rearrange their internal components. 
Morphological changes of all cells are directed by a filamentous system of 
interconnected proteins called the cytoskeleton. In eukaryotic cells the 
cytoskeleton consists of three different types of filaments: microtubules (1.5), 
intermediate filaments (1.6) and actin (1.7). 
 
1.5 Microtubules 
Microtubules are hollow filaments with a diameter of ~24 nm, each filament is 
built up of 13 protofilaments which are laterally bound to each other (figure 
3A). Each protofilament is a chain made up of α- and β-tubulin dimers 
(Molodtsov et al., 2005; Nogales, 2000). Within the cytoplasm heterodimers of 
α- and β-tubulin are present, and can bind the existing filaments. Microtubules 
are highly dynamic, with a slow growing minus end and a fast growing plus 
end (Wade and Hyman, 1997). In non-neuronal cells, almost all microtubule 
minus-ends are attached to the centrosome or microtubule organizing centre 
(MTOC), whereas in neurons  few microtubules are bound to the centrosome. 
The centrosome or MTOC is a ring-like structure where nucleation of the 
microtubule takes place. γ-Tubulin, a protein with high homology to α- and β-
tubulin, plays an essential role in microtubule nucleation in providing a 
template for the 13-protofilament microtubule structure (Bornens, 2002; 
Nogales, 2000). 
 
 
 
 
 
Figure 3 The cytoskeleton consists of microtubules (A), intermediate 
filaments (B) and actin microfilaments (C). 
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Both α- and β-tubulin monomers bind a GTP molecule at the nucleotide 
exchangeable site (E-site). During microtubule polymerization, GTP-bound 
tubulin heterodimers are added to the exposed ends. The GTP bound to the 
tubulin heterodimers is not immediately hydrolyzed because β-tubulin is a 
weak GTPase. As the polymer continues to assemble, GTP is hydrolyzed to 
GDP. As result of GTP hydrolysis, the plus end generally has a multilayer GTP 
cap of approximately five or more tubulin layers (Schek et al., 2007). However, 
if dimer addition is faster than that of GTP hydrolysis, the size of the GTP cap 
will increase. In contrast, if GTP hydrolysis exceeds microtubule assembly, 
GDP-tubulin subunits will appear at the microtubule tip. GDP bound β-tubulin 
can assume a curved conformation. This conformation will break up the 
lateral interactions between protofilaments. This results in microtubule 
disassembly at the plus-end. Because all of the tubulin inside the microtubule 
filament is in the GDP conformation, depolymerization is a rapid process 
(Nogales, 2000; Schek et al., 2007). 
 
1.5.1 Microtubule binding proteins 
The stability of microtubules is regulated by microtubule associated proteins 
(MAPs). MAPs can be divided into a number of distinct subgroups based on 
their site of binding to the microtubule (e.g. the microtubule lattice or the plus 
ends so called +TIPs proteins). MAPs can also be categorized based on their 
functional properties: those that stabilize the microtubule (e.g. MAP2, tau) 
and those that destabilize the microtubule (e.g. MCAK, Op18/Stathmin, 
XKLP2). Whether MAPs stabilize or destabilize MTs is a sum of the overall 
dynamics of microtubules: their growth and collapse rate and their frequency 
of switching between polymerization and depolymerization (catastrophe and 
rescue). Examples of each are stated below. 
 
1.5.2 Microtubule stabilizing proteins 
Archetypical stabilizing MAPs are MAP2 and tau in neurons and MAP4 in non-
neuronal cells. These MAPs bind to the surface of microtubules, interacting 
with multiple tubulins with their C-terminus, stabilize them and promote 
assembly (Heald and Nogales, 2002). The N-terminal part is thought to project 
out of the microtubule surface and interacts with other cytoplasmic 
components. In neurons, the microtubule stabilizing effect of MAP2 and tau is 
observed as an increase in the polymerization and rescue rate and a 
decreased rate of catastrophes (Desai and Mitchison, 1997). MAP2 does not 
only bind to microtubules, it can also associate with actin microfilaments, 
membrane organelles and the post-synaptic density in dendritic spines 
(Caceres et al., 1984; Dehmelt and Halpain, 2005; Farah et al., 2005). 
 
Chapter 1 
 
1 8  |  P a g e  
 
 Polymerization Depolymerization Frequency of 
rescue 
Frequency of 
catastrophe 
MAP2 ↑  ↑ ↓ 
Tau ↑  ↑ ↓ 
XMAP215 ↑↑ ↑ ↑  
EB-1    ↓ 
 
 
Several splice-variants of MAP2 are expressed in brain tissue, some of which 
show developmentally regulated expression (Shafit-Zagardo and Kalcheva, 
1998). For example, MAP2A is expressed only in mature brain whereas MAP2B 
is expressed both in the developing brain and the mature brain. MAP2C is 
highly expressed during development and down-regulated during 
maturation. Glial cells abundantly express MAP2D.  
MAP2 can be phosphorylated by cAMP-dependent protein kinases (e.g. 
CamKII, PKA, PKC, cdc2 kinase) and dephosphorylated by protein 
phosphatases (PP1, PP2A, PP2B). The binding efficiency of MAP2 to tubulin 
depends on its phosphorylation status (Avila et al., 1994; Itoh et al., 1997).  
Several distinct Tau splice-variants have been described. One class of Tau 
isoforms contains three tubulin-binding motifs and is mainly expressed in the 
developing brain. Another class of Tau isoforms contains four tubulin-binding 
motifs and is mainly expressed in the mature brain. Tau is predominantly 
localized to the neuronal axon, where it is required for its elongation. Tau can 
be phosphorylated by kinases like CamKII, PKC and Cdk5 and 
dephosporylated by protein phosphatases like PP2A and PP2B. 
Phosphorylated and dephosphorylated Tau exhibit decreased and increased 
affinity for tubulin respectively. A hyperphosphorylation of Tau proteins is 
found in several neurodegenerative disorders, like Alzheimer’s disease (Avila 
et al., 1994). 
 
TOGp (XMAP215) was first discovered in Xenopus eggs and is expressed in 
ectodermal and neuroectodermal tissue during development. XMAP215 
strongly increases the polymerization rate of pure tubulin, but only the plus 
ends, thereby affecting the dynamics of microtubules in a different manner 
compared to the classical MAPs (Becker and Gard, 2000; Charrasse et al., 
1998). XMAP215 binds to the microtubule plus-end and stabilizes weakly 
attached tubulin dimers (Brouhard et al., 2008). XMAP215 also increases the 
rate of rapid depolymerization and decreases the rescue frequency, 
increasing the microtubule turnover (Kinoshita et al., 2002). In the brain TOGp 
Table 1 Microtubule stabilizing proteins. ↑ increase, ↓ decrease. 
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is abundantly expressed in the Purkinje cells of the cerebellum (Charrasse et 
al., 1996). 
 
EB1 binds to the tips of growing microtubules and is therefore called an +TIP 
protein. In mitosis EB1 stabilizes the tubulin polymer by preventing 
catastrophes (Tirnauer et al., 2002). EB1 is highly expressed in the distal axon of 
neurons. EB1 can interact with most other +TIPs (e.g. APC, CLASPs, CLIPs) 
(Akhmanova and Hoogenraad, 2005; Gu et al., 2006). 
 
1.5.3 Microtubule destabilizing proteins 
The high frequency of catastrophe in cells compared to the frequency of 
catastrophe observed with pure tubulin in vitro suggested the existence of 
factors that promoted catastrophes. It was hypothesized that these factors 
underlie rapid changes in microtubule dynamics, for example during 
interphase-mitosis transition. 
 
 Polymerization Depolymerization Frequency of 
rescue 
Frequency of 
catastrophe 
Op18/stathmin ↓   ↑ 
Katanin    ↑ 
MCAK  ↑  ↑ 
 
 
The first microtubule destabilizing protein identified was Op18/stathmin, which 
is expressed in the cytosol of neurons (Belmont and Mitchison, 1996; Curmi et 
al., 2000; Hanash et al., 1988; Himi et al., 1994; Ohkawa et al., 2007; Price et al., 
2000). Op18/stathmin sequesters tubulin dimers, which leads to lower tubulin 
dimer concentrations. Lower tubulin concentrations have two effects, it slows 
microtubule growth and induces catastrophe by promoting the hydrolysis of 
microtubules by removal of the stabilizing GTP cap (Cassimeris, 2002; Heald 
and Nogales, 2002). 
Katanin is a distinct microtubule destabilizing protein. It destabilizes polymers 
by removing the GTP-cap, generating new ends (Hartman et al., 1998; 
McNally and Thomas, 1998; McNally and Vale, 1993). In effect, katanin severs 
microtubules and is essential for releasing microtubules from the neuronal 
centrosome (Ahmad et al., 1999). The releasing from the centrosome is 
necessary for the transport of microtubules into the axon (Ahmad et al., 1994). 
 
Tradionally kinesins are proteins that move along the microtubule lattice, 
however some kinesin-like proteins cause destabilization of microtubules. An 
Table 2 Microtubule destabilizing proteins. ↑ increase, ↓ decrease. 
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example of such “catastrophe kinesin” is MCAK. MCAK uses ATP to destabilize 
both microtubule ends and causes a conformational change, which results in 
protofilament ´peeling´ (Desai et al., 1999; Howard and Hyman, 2003; Hunter 
et al., 2003; Kinoshita et al., 2006; Walczak et al., 1996). 
 
1.5.4 EMAP family 
The most abundant MAP in dividing sea urchin eggs and embryos is the 
echinoderm microtubule associated protein (EMAP) (Li and Suprenant, 1994; 
Suprenant et al., 1993). EMAP is a 77 kDa polypeptide with almost no 
homology to other MAPs (Li et al., 1998). Five EMAP homologs have been 
identified in mammals (EML1-5)(Eudy et al., 1997; Heidebrecht et al., 2000; Jin 
et al., 2004; Lepley et al., 1999; O'Connor et al., 2004; Pozuelo Rubio et al., 
2004). 
 
 
 
 
 
The sequence of EMAP is highly conserved during evolution. Several distinct 
domains are present within the primary protein structure. The hydrophobic 
EMAP-like protein (HELP) domain is unique for this family and is localized at the 
N-terminal end of the protein (figure 4). The HELP domain is a hydrophobic 
domain that is thought to be involved in microtubule binding (Eichenmuller et 
al., 2001; Li and Suprenant, 1994). 
Multiple WD40 domains are present at the C-terminal end of the protein. 
These domains are putative protein-protein interaction domains that can form 
a blade of a propeller-like structure. A coiled-coil domain is present in most of 
the mammalian EMAPs. This domain is a putative dimerization domain, 
suggesting Emls can form homo- or heterodimers (Lupas et al., 1991). 
 
In vitro EMAP binds with a high affinity to both microtubules and tubulin 
dimers. It effects microtubule dynamics as microtubules are slightly longer in 
the presence of EMAP. EMAP reduces the frequency of rescue (Eichenmuller 
Figure 4. HELP domain evolutionary conserved. The HELP domain of all mouse Emls 
compared with Emls from e.g. drosophila, c. elegans and xenopus. Arrows: conserved 
amino acid; * conserved amino acid except for one specie. 
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et al., 2001; Hamill et al., 1998; Nogales, 2000). Similar to other MAPs, EMAP 
can be phopshorylated. EMAP is, on average, constitutively phosphorylated 
on 5 serine residues (Brisch et al., 1996; Li and Suprenant, 1994). p34cdc2 
phosphorylates EMAP in a cell-cycle dependent manner. 
 
Mammalian homologs 
Eml1 (ELP79/HuEMAP-1) was isolated as a protein product within the Usher1a 
locus (Eudy et al., 1997). Usher syndrome is an autosomal recessive disorder 
that manifests as congenital deafness, retinitis pigmentosa and balance 
problems. So far at least 13 distinct loci have been associated with Usher 
syndrome. Three types of Usher syndrome have been described, children with 
Usher type I are born deaf and have balance problems. During childhood, 
around the age of 10, these children develop retinitis pigmentosa and 
become blind. Children with type II have hearing disabilities, no balance 
problems and the retinitis pigmentosa starts around puberty. Usher syndrome 
type III is characterized by a normal hearing and vision at birth with varying 
onset of hearing disability and blindness (Sankila et al., 1995; Smith et al., 
1994). Eml1 is also found as a fusion protein with ABL1 in T-cell acute 
lymphoblastic leukemia. Normally Eml1 is not expressed in leukemic cells (De 
Keersmaecker et al., 2005).  
Eml2 (ELP70/HuEMAP-2) is localized to chromosome 19 and is mainly 
expressed in heart, brain, placenta pancreas, colon, thyroid, spinal cord and 
adrenal gland (Lepley et al., 1999). Within the brain, Eml2 is expressed in the 
inferior and superior colliculi and in nuclei of the brainstem. A relatively low 
expression of Eml2 is found in cortex, hippocampus and cerebellum (Ly et al., 
2002). Eml2 is a microtubule destabilizing protein, it decreases the nucleation, 
decreases the elongation length and increased the catastrophe rate 
(Eichenmuller et al., 2002). Eml2 is also described as a binding partner of the 
delta1 and delta2 glutamate receptor (Ly et al., 2002). 
Eml3 (ELP95) is localized to chromosome 11, and interacts with 14-3-3 in HeLa 
cells (Jin et al., 2004; Pozuelo Rubio et al., 2004).  
Eml4 (ELP120/ROPP120/C2ORF2) is localized to chromosome 2, was found to 
be “overexpressed” during mitosis (Heidebrecht et al., 2000). Eml4 binds to 
microtubules and is essential for the formation of a microtubule network 
(Pollmann et al., 2006). Eml4 is also found as a fusion protein in lung cancer 
where Eml4 is fused N-terminally to the ALK tyrosine kinase. Both the basic, 
HELP and WD40 domains are necessary for the formation of the tumor 
(Meyerson, 2007; Soda et al., 2007).  
Eml5 was first described by our group (O'Connor et al., 2004) and contains a 
2.5 fold repeat of the complete EMAP protein. Eml5 is also found as a 
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quantitative trait loci for intramuscular fat content (Sato et al., 2006). The role 
of any Eml in neurons is not yet described. 
 
1.6 Intermediate filaments 
Intermediate filaments have a diameter of approximately 10 nm (figure 3B). 
All intermediate filaments contain (1) a N-terminal head domain, which is 
important for self-assembly by phosphorylation; (2) a highly conserved central 
α-helical rod domain, essential for the packing of the α-helical coil and for 
co-assembly; and (3) a C-terminal tail domain needed for self-assembly and 
important for interaction with other cytoskeleton elements (Rutka et al., 1997).  
The intermediate filaments can be divided into at least five distinct types 
encoded by approximately 65 human genes. Type I and II are, respectively, 
the acidic and basic keratins, type III include desmin, vimentin, glial fibrillary 
acidic protein and peripherin. The neuron specific intermediate filaments NF-
L, NF-M and NF-H form the type IV together with nestin, α internexin, syncoilin 
and synemin. In type V intermediate filaments are the lamins, which have a 
structural function in the nucleus. Filensin and Phakinin are intermediate 
filaments that are not yet divided into any type of intermediate filaments 
(Barry et al., 2007; Oshima, 2007). 
 
1.7 Actin 
Actin is the most abundant cytoskeletal protein in the cell and is encoded by 
6 genes (three alpha, one beta and two gamma actin). The total pool of 
actin consists of polymerized, filamentous (F) actin and unpolymerized, 
globular (G) actin. Only a small portion of the globular actin is not in a 
complex with other proteins. G-actin is essential for rapid reorganization of the 
network when motility is needed. ATP-bound actin monomers polymerize 
head-to-tail to form filamentous actin. Two parallel F-actins form a rod-like 
helical filament (microfilament) with a diameter of 5-7 nm (figure 3C). 
Actin filaments have an intrinsic polarity, both in their structure and in their 
way of assembly. The two ends of the filament polymerize at different rates 
resulting in a fast growing plus (or barbed) end and a slower growing minus 
(or pointed) end (Wegner, 1976). 
Polymerization starts with the formation of a nucleation site. Nucleation sites 
can be formed de novo, from the sides of existing filaments or by severing of 
an existing filament. Once nucleated, rapid polymerization occurs and ATP-
bound monomers are added to the exposed ends of the growing polymer. As 
the filaments matures, the ATP is hydrolyzed and ADP-actin is released from 
the pointed end. Nucleotide exchange regenerates ATP-actin monomers that 
can again be added to the growing end of the filament. After the initial fast 
polymerization, an equilibrium phase is reached when the growth of polymer 
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due to monomer additions is precisely balanced by the shrinkage due to 
monomer loss. At this point, the net length of the filament remains constant, 
even though polymer addition and loss continues. This process is called 
‘treadmilling’ (Margolis et al., 1978). 
Actin filaments form short polymers: they are concentrated at the cell’s 
periphery in the cortical cytoplasm lying just underneath the plasmalemma, 
where, together with a large number of actin-binding proteins (e.g. secrin-
fodrin, ankyrin, talin and actinin), they form a dense network. This matrix plays 
a key role in the dynamic function of the cell’s periphery, such as the motility 
of growth cones during development, generation of specialized 
microdomains on the cell surface, and the formation of pre- and postsynaptic 
morphologic specializations. 
 
1.7.1 Actin binding proteins 
The dynamics of the actin cytoskeleton is regulated by actin binding proteins 
(ABPs). The molecular mechanism ABPs use to influence the actin 
microfilament on the molecular level are diverse (figure 5). Their net result on 
actin polymerization determines whether ABPs stabilize or destabilize actin 
filaments. Different approaches can be used by an ABP, namely nucleating, 
capping, severing, crosslinking, bundling, sequestering, delivering monomers 
or promoting monomer nucleotide exchange. 
 
 
Examples of ABP with different approaches to stabilize or destabilize the actin 
filaments are given below. 
1) α-Actinin, an actin cross-linking protein, that does not bind to G-actin, but 
binds reversibly to F-actin (McGough et al., 1994; Miyata et al., 1996). α-
Figure 5. A model of an actin 
filament with divers ABP 
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Actinin organizes actin filaments in a parallel fashion, like in a contracting 
network (Biron and Moses, 2004; Nakagawa et al., 2004).  
2) the Arp2/3 complex consist of 7 polypeptides and was first identified based 
on its affinity to profilin. The Arp2/3 complex is activated by the nucleation-
promoting factor (NPF) resulting in the formation of new filaments from the 
existing filament with a regular angle of 70˚ (Goley and Welch, 2006). 
3) Caldesmon, an ABP with two actin binding sites within its C-terminus. Both 
sites bind with adjacent actin microfilaments forming interstrand interactions. 
The net result of these interstrand “crossbridges” is an increase in filament 
length by 1.6 fold (Greenberg et al., 2007). 
4) Tropomyosin, an ABP that forms a cable along the actin microfilament 
lattice. By forming this cable, Tropomyosin strengthens the monomer-
monomer intrastrand interaction within one F-Actin filament. As a result of this 
stabilization, the actin filament remains 1.5-2.0 times its ‘normal’ length 
(Greenberg et al., 2007). 
5) ADP/cofilin is a small protein of about 15-20 kDa. It binds preferentially to 
GDP-F-actin, causing a twist of the microfilament of 5˚. As a result, the actin 
filament depolymerizes. ADP/cofilin can be regulated by phosphorylation. 
Phosphorylation causes a reduced affinity to actin though the physiological 
effects of this remains to be investigated (Paavilainen et al., 2004). 
6) The gelsolin family of ABPs consists of seven different proteins: gelsolin, 
adseverin, villin, capG, advillin, supervillin and flightless I. Gelsolin, the 
founding member of this family, can bind actin filaments and severs them, 
cap the plus end and assist in the formation of polymerization nucleation sites. 
Gelsolin, is a calcium activated ABP.(Silacci et al., 2004; Sun et al., 1999). 
 
1.7.2 Synaptopodin 
Synaptopodin is a proline-rich actin associated protein, expressed in 
differentiated renal podocytes, in the spine neck of telencephalic neurons, 
and in the axonal initial segment (Bas Orth et al., 2007; Mundel et al., 1997). In 
the spine neck Synaptopodin associates with F-actin, α-actinin and the spine 
apparatus. In the axonal initial segment Synaptopodin associates with the 
cisternal organelle (Bas Orth et al., 2007; Bas Orth et al., 2005; Deller et al., 
2003; Deller et al., 2000a; Deller et al., 2000b; Deller et al., ; Kremerskothen et 
al., 2005). 
 
Synaptopodin has two ‘close’ homologs: Myopodin and Fesselin (Leinweber 
et al., 1999; Schroeter and Chalovich, 2005; Weins et al., 2001). 
Myopodin shares significant sequence homology to Synaptopodin and is 
expressed as a 80 kDa protein in skeletal muscles, colon, stomach, uterus and 
lung and as a 95 kDa protein in the heart. These two different protein sizes are 
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either due to splice variants or post-translational modifications. Within the 
muscle cells Myopodin localizes with the Z-disc, a line that divides the 
sacromeres (Weins et al., 2001). Fesselin, a 103 kDa protein, is expressed in 
smooth muscle cells (Leinweber et al., 1999). Furthermore it is known that 
Fesselin is regulated by Calmodulin, through this pathway the Ca2+ levels 
affect the polymerization of actin (Kolakowski et al., 2004; Schroeter and 
Chalovich, 2004). 
 
Synaptopodin can bind to the actin cytoskeleton and rearrange the 
microfilaments (Asanuma et al., 2005). In addition, Synaptopodin interacts 
with α-actinin (an actin binding protein), MAGI (a member of the MAGUK 
scaffolding proteins) and, RhoA (a Ras homologue known to regulate stress 
fiber formation) (Asanuma et al., 2005; Asanuma et al., 2006; Kremerskothen 
et al., 2005). Although Synaptopodin associates with actin, and other proteins 
its functional domains remain to be characterized. 
Synaptopodin expression is upregulated after neuronal activity (Deller et al., 
2007; Fukazawa et al., 2003; Kikuno et al., 1999; Matsuo et al., 1998; Matsuo et 
al., 2000; Roth et al., 2001; Yamazaki et al., 2001) and Synaptopodin knock out 
mice show loss of LTP, impaired spatial learning, and loss of spines with a spine 
apparatus. 
In conclusion, these data suggest a role for Synaptopodin and the spine 
apparatus in synaptic plasticity. However, the underlying mechanism still has 
to be unraveled. 
 
 
1.8 Scope of this thesis 
The cytoskeleton of neurons is highly dynamic. Therefore detailed analysis of 
cytoskeletal proteins in the mammalian brain is essential to understand the 
role of the cytoskeleton during development and neuronal plasticity. 
In Chapter 2 we describe Eml4, a member of the echinoderm microtubule 
associated protein (EMAP) family that shows developmentally regulated 
expression. We show that Eml4 expression is maintained at low levels in the 
adult mouse olfactory bulb, hippocampus and cerebellum. Functional 
analysis demonstrates that Eml4 is a microtubule stabilizing protein. In Chapter 
3 we describe the cloning and expression of a novel member of the EMAP 
family, Eml5. We concluded that rat Eml5 is expressed in rat olfactory bulb, 
hippocampus and cerebellum. Eml5 is unusual because it contains tandem 
repeats of the typical EMAP domains. In Chapter 4 we functionally 
characterized Synaptopodin, a protein that bundles the actin cytoskeleton in 
neurons. We provide evidence for the presence of at least two Synaptopodin 
splice variants in rat brain. Only one of these isoforms shows activity 
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associated expression. Functionally, the activity associated Synaptopodin 
isoform can modify the actin cytoskeleton perhaps by recruitment of other 
actin bundling proteins like α-Actinin. 
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Abstract 
Echinoderm microtubule-associated protein (EMAP) is the major microtubule 
binding protein in dividing sea urchin (Strongylocentrotus purpuratus) eggs. 
Echinoderm microtubule-associated protein like protein 4 (Eml4, restrictedly 
overexpressed proliferation-associated protein 120 kDa (Ropp120)) is one of 
the five mammalian EMAP homologues, the cellular function of which remains 
to be elucidated. In our first set of experiments we determined the spatio-
temporal expression pattern of Eml4 in mouse brain. Our results demonstrate 
that Eml4 is a highly developmentally regulated gene with high expression 
levels in the developing nervous system of E11 embryos declining to low levels 
in adult. Spatially, Eml4 expression becomes restricted to the olfactory bulb, 
hippocampus and cerebellum. Transient transfection of a fusion construct of 
full-length mouse Eml4 with green fluorescent protein (GFP-Eml4) into Cos7 
and HeLa cells resulted in colocalization of GFP-Eml4 with microtubules. This 
colocalization was observed both with microtubules of non-dividing cells and 
with the mitotic spindle of dividing cells. In addition, transient overexpression 
of GFP-Eml4 in Cos7 cells resulted in microtubules that were resistant to 
nocodazole treatment suggesting that Eml4 stabilizes microtubules. A 
consequence of microtubule stabilization is a net reduction in the amount of 
free tubulin. Microtubule stabilizing proteins therefore are expected to 
indirectly decrease the microtubule growth rate. Indeed, transient 
transfection of GFP-Eml4 resulted in a marked decrease in the microtubule 
growth rate, which is in line with our hypothesis that Eml4 functions as a 
microtubule stabilizing protein. In summary, our results suggest that Eml4 is a 
developmentally regulated protein that colocalizes with and stabilizes 
microtubules.  
 
Introduction 
Microtubules are polymers made up of alpha- and beta-tubulin subunits that 
provide the architectural structure of eukaryotic cells (Nogales, 2000). They 
play a role in various cellular processes, such as cell division, intracellular 
transport and cell motility. Microtubules are bipolar structures with their minus-
end anchored in the microtubule-organizing center (MTOC) and their plus-
ends directed toward the cell membrane. In neurons however, the 
microtubule network is slightly different from other eukaryotic cells: in the 
axon, microtubules are oriented with their plus ends away from the soma, 
while in the dendrites the microtubules are oriented in both directions (Baas, 
1999). 
Microtubules are highly dynamic structures that can switch between growing 
and shrinking phases (Heald and Nogales, 2002; Howard and Hyman, 2003; 
Nogales, 2000). Microtubule dynamics are regulated by their interaction with 
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microtubule-associated proteins (MAPs) of which many have been identified 
(Desai and Mitchison, 1997; Itoh and Hotani, 2004; Nogales, 2000). The MAPs 
can generally be classified into two categories, microtubule-stabilizing 
proteins (e.g. MAP2, cytoskeleton-associated protein 2 (CKAP2) and tau) and 
microtubule-destabilizing proteins (e.g. stathmin, katanin) (Ahmad et al., 1999; 
Cassimeris, 2002; Kalcheva et al., 1998). 
In dividing sea urchin eggs the most abundant MAP is echinoderm 
microtubule-associated protein (EMAP) (Suprenant et al., 1993). Interestingly, 
several mammalian homologs of EMAP, EMLs (EMAP-like proteins) have been 
identified. These include: 1) EML1 (echinoderm microtubule-associated 
protein-like protein (ELP)79/HuEMAP-1), a candidate for Usher-1a (Eudy et al., 
1997), 2) EML2 (ELP70/HuEMAP-2) (Lepley et al., 1999), 3) EML3 (ELP95) (Jin et 
al., 2004; Pozuelo Rubio et al., 2004), 4) EML4 (ELP120/restrictedly 
overexpressed proliferation-associated protein 120 kDa 
(ROPP120)/chromosome 2 open reading frame 2 (C2ORF2)) (Heidebrecht et 
al., 2000; Pollmann et al., 2006), a member that was found to be 
“overexpressed” during mitosis and, 5) Eml5, recently cloned in our group 
from adult rat brain (O'Connor et al., 2004). 
 
 
 
 
 
The protein sequences of all five EMLs are highly conserved (Figure 1). They all 
contain a hydrophobic EMAP like (HELP; hydrophobic echinoderm 
microtubule-associated protein-like protein) domain that is unique to this 
family and multiple WD40 domains (Hamill et al., 1998; Li et al., 1998; Pollmann 
et al., 2006; Suprenant et al., 2000). Although evidence suggests that EMAP 
and EML2 associate with microtubules and regulate their dynamics 
(Eichenmuller et al., 2002; Hamill et al., 1998; Suprenant et al., 1993), the 
Figure 1. Schematic drawing of Eml proteins showing conserved HELP- and WD40 domains,
an EF-hand and helical coiled-coil region. 
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cellular function of other EMAP family members remains to be determined. 
We therefore set out to examine the cellular function of one of the murine 
members of the EMAP protein family, Eml4. In this study we examine its spatio-
temporal expression pattern, alternative splicing and, provide evidence that 
Eml4 associates with and stabilizes microtubules.  
 
Materials and Methods 
Tissues 
Whole embryos (embryonic day (E) 11, 15 or 18) or brains from postnatal day 
(P) 1, 10 or adult mice (C57/Bl6, Harlan, Horst, The Netherlands) were carefully 
removed, frozen on dry ice and stored at −80 °C; 14 µm sections were cut on 
a cryostat, mounted onto superfrost plus (Menzel-Glaser, Braunschweig, 
Germany) glass slides and stored at −80 °C. The housing of the mice was in 
filter-top units, with extra nesting material for pregnant mice. All animal 
experiments were performed in accordance with the recommendations of 
the European Communities Council Directive of 24 November 1986 
(86/609/EEC) and were conducted with the approval of the Dutch Ethical 
Committee for animal experiments. All efforts were made to minimize animal 
suffering. 
 
In situ hybridization (ISH) 
Radioactive and non-radioactive ISHs were performed essentially as 
described (French et al., 2001). For radioactive ISH, sections were thawed, 
fixed in 4% paraformaldehyde, acetylated in 1.4% triethanolamine and 0.25% 
acetic anhydride, dehydrated through graded ethanol solutions and 
delipidated in chloroform. Sections were hybridized overnight at 42 °C in 100 
µl buffer containing 50% formamide, 4× SSC, 10% dextran sulfate, 5× 
Denhardt’s solution, 200 mg/ml acid alkali cleaved salmon testis DNA, 100 
mg/ml long-chain polyadenylic acid, 25 mM sodium phosphate (pH 7.0), 1 
mM sodium pyrophosphate and 100,000 CPM radiolabeled probe (approx. 
1ng/ml) under parafilm coverslips. Sections were subsequently washed in 1× 
SSC at 55 °C (30 min), 0.1× SSC at room temperature (5 min) and dehydrated 
in ethanol. Hybridized sections were then exposed to autoradiographic film. 
35S-ATP end-labeled probes (Amersham, Munich, Germany) were generated 
using terminal deoxynucleotidyl transferase (Promega, Leiden, The 
Netherlands) according to manufacturer’s instructions. A 50-fold excess of 
unlabeled antisense oligonucleotide was used as negative control. Sequence 
of the Eml4 antisense oligonucleotide (Invitrogen, Paisley, UK) was 5′-
GCGGTCTTGAACGTCAGAGGTACTTGCAGCAGAAATACTATCATC-3′ 
corresponding to amino acids 9–23 (AAH70427). Sections were 
counterstained with hematoxylin and eosin. For non-radioactive ISHs, sections 
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were fixed in 4% paraformaldehyde, acetylated in 1.4% triethanolamine, 
0.25% acetic anhydride and washed in phosphate-buffered saline (PBS). 
Sections were then prehybridized (1 h) in buffer containing 50% formamide 
(Sigma, Zwijndrecht, The Netherlands), 5× SSC, 5× Denhardt’s (Sigma), 250 
µg/ml yeast tRNA (Roche, Almere, The Netherlands) and 500 µg/ml acid-alkali 
cleaved salmon testis DNA (Sigma). Hybridization was performed overnight at 
65 °C in prehybridization buffer containing 100 ng/ml digoxigenin–UTP-labeled 
cRNA probes. Antisense and sense probes directed against bp 2139–2719 
(amino acids: 714–907 of AAH70427) were generated using DIG RNA labeling 
kit (Roche) according to manufacturer’s instructions. Following hybridization, 
sections were washed in 0.2× SSC at 65 °C and blocked in 0.1M Tris pH 7.5, 
0.15 M NaCl and 10% heat-inactivated sheep serum (Sigma) for 1 h at RT. 
Alkaline phosphatase conjugated anti-digoxigenin antibodies (Roche) were 
added to the sections in a dilution of 1:5000 in 0.1 M Tris pH 7.5, 0.15 M NaCl 
and 1% heat-inactivated sheep serum and incubated overnight at 4 °C. 
Following washing of the sections, color reactions were performed in 0.1 M Tris 
pH 9.5, 0.1 M NaCl, 50 mM MgCl2, 2 mM levamisole (Sigma), 0.35 mg/ml nitro-
blue tetrazolium (Roche) and 0.18 mg/ml 5-bromo-4-chloro-3-
indolylphosphate (Roche). Reactions were terminated upon visual inspection 
(~18 h) and mounted in Permount (Fisher Scientific, Loughborough, UK). 
 
Reverse transcriptase–polymerase chain reaction (RT-PCR) 
Total RNA from adult mouse brain was isolated using Trizol (Invitrogen) 
according to manufacturer’s guidelines. cDNA was synthesized from 2 µg 
isolated RNA using a T18 oligonucleotide in the presence of 200U Superscript III 
(Invitrogen), 10 mM dNTPs, 40 U RNasin (Promega), 0.01 M DTT for 1 h at 50 °C. 
Full-length Eml4 constructs were amplified from the cDNA using 5′-
GCAAGCTCCCGTTAGACATCTGAG-3′ and 5′-GCAAGATGGACGGGTTTC-3′ 
oligonucleotides. The fragment was cloned into pEGFP-C2 vector (Invitrogen), 
in which EGFP is fused N-terminally to full length Eml4, and sequence verified. 
For the splicing PCR we used the following primers: 131: 5′-
AAGATGGACGGTTTCGCCGG-3′, 134: 5′-TTTTTCACTGAGGCTACATGATC-3′; 
135: 5′-CGAGAAGCTATTTCTATGTCCTG-3′; 140: 5′-
GATTGACGATGACATCTTTATG-3′; 139: 5′-CATAAAGATGTCATCGTCAATC-3′; 
143: 5′-AGGAATGAACATTGTAATTGGCC-3′. 
 
Antibodies 
We generated a peptide-antibody (1139) against amino acids 118–132 of 
Eml4 (primary sequence IKRPPTAEKSHNSWE). Adult New Zealand White rabbits 
were immunized with 50–100 µg peptide using Freund’s complete adjuvant 
(Eurogentec, Seraing, Belgium). The immunization was followed by four boosts 
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of 50–100 µg administered every 2 or 3 weeks in Freund’s incomplete 
adjuvant. Serum was taken 24 days after the final boost. 
 
Western blot 
Proteins were isolated from mouse E11 embryos, E15 brain, E18 brain, adult 
brain (olfactory bulb, cortex, hippocampus, cerebellum and brainstem) and 
transiently transfected Cos7 cells. Isolations were performed in ice-cold PBS 
containing 1% SDS and protease inhibitor cocktail (Sigma). Homogenized 
tissues or lysed cells were incubated on ice for 20 min and centrifuged to 
eliminate protein insoluble fractions. Protein concentrations were measured 
using BCA (Pierce, Perbio Science, Etten-Leur, The Netherlands) according to 
the manufacturer’s guidelines. Samples diluted in Laemmli sample buffer (LSB; 
50 mM Tris–HCl, pH 6.8, 2.5% v/v SDS, 12.5% v/v glycerol, 0.01% w/v 
Bromophenol Blue, 100 mM DTT, β-mercaptoethanol) were denatured for 5 
min at 95 °C, after which 20 µg of protein was transferred to 10% or 6% 
acrylamide gels. Following electrophoresis, gels were wet-blotted on either 
PVDF (Bio-rad, Veenendaal, The Netherlands) or nitrocellulose (Bio-rad) 
overnight and blocked in TBS containing 5% milk (Nutricia, Cuijk, The 
Netherlands) and 1% Tween. Serum 1139 (1:500), pre-immune serum (1:500) or 
anti-green fluorescent protein (GFP) (Abcam, Cambridge, UK; 1:5000) was 
added to the blots in TBS containing 2% milk and 1% Tween (TBS-T). Next day 
the blots were washed and incubated with secondary antibody (swine-anti-
rabbit-HRP or rabbit-anti-mouse-HRP, 1:5000 Dako, Glostrup, Denmark) in TBS-T. 
The blots were then washed in TBS/1% Tween following which we measured 
signals on the blot using chemiluminescence (Amersham) according to the 
manufacturer’s instructions. 
 
Transient transfection 
Cos7 cells, grown in two-well chambered coverglasses (NalgeNunc, 
Naperville, IL, USA) were transfected using DEAE-dextran (O'Connor et al., 
2004). In brief, cells were incubated for 30 s in serum free medium containing 
0.5 mg/ml DEAE-dextran (Sigma). Cells were then exposed to GFP-Eml4 
and/or end-binding protein (EB)3–monomeric red fluorescent protein (mRFP) 
(kindly donated by A. Akhmanova, Erasmus MC, Rotterdam, The Netherlands) 
expression vectors (total DNA amount per well of 1 µg) in the presence of 0.1 
mM chloroquine for 2–4 h. Cells were then incubated in 10% dimethyl sulfoxide 
in PBS for 90 s and returned to normal medium (10% fetal calf serum, 45% 
DMEM and 45% F-10, 500 U/ml penicillin and 500 U/ml streptomycin). HeLa 
cells, grown in two-well chambered coverglasses (NalgeNunc) were 
transfected using DNA/Ca2+-phosphate co-precipitation as described by 
Kohrmann et al. (1999). Briefly, fresh serum free culture medium (Cos7 culture 
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medium) was added to HeLa cells 1–4 h before transfection. The cells were 
then incubated for 0.5–2 h with 120 µl containing 5–10 µg DNA, 125 µM CaCl2, 
140 mM NaCl, 0.75 mM Na2HPO4 and 25 mM BES pH 7.1, which was added to 
the medium. The forming of the calcium phosphate precipitates was visually 
inspected. Cells were then washed twice with prewarmed HBS (135 mM NaCl, 
4 mM KCl, 1 mM Na2HPO4, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 20 mM 
Hepes, pH 7.35) and returned to normal medium. Eighteen hours to 48 h after 
transfection, cells were fixed in ice-cold methanol (100%), 1 mM EGTA (10 min) 
followed by 4% paraformaldehyde in PBS (10 min). Cells were permeabilized 
in 0.1% saponin/PBS, and blocked with PBS containing 1% BSA, 10% fetal calf 
serum before being incubated (overnight) with beta-tubulin antibodies 
(Sigma tub clone 2.1; 1:300). Following washing in PBS, cells were incubated (1 
h) with the secondary antibody (Alexa-fluor goat-anti-mouse 594, dilution 
1:300; Molecular Probes, Invitrogen). Slides were mounted in Vectashield 
mounting medium (Vector Laboratories, Burlingame, CA, USA) containing 
DAPI. For nocodazole treatment: Cos7 cells were incubated for 20 min with 10 
µM nocodazole (Sigma) 18 or 48 h post-transfection with GFP-Eml4. 
 
Imaging 
Fluorescence images where made using a Leica (Wetzlar, Germany) DMRBE 
microscope with a 40× oil immersion objective coupled to a Hamamatsu 
(Hamamatsu Photonics K.K.; Hamamatsu City, Japan) C4880 CCD camera or 
using a Zeiss (Jena, Germany) LSM510 confocal laser-scanning microscope 
using a 63× oil immersion objective. For live imaging, cells were analyzed on 
the confocal microscope at 37 °C, under 5% CO2 in culture medium. In our 
experiments we used an optical slice of ~1 µm, images were taken every 
second. Microtubule growth was measured as the traveled distance of EB3–
mRFP (kindly donated by A. Akhmanova), a plus-end microtubule binding 
protein fused to RFP (Akhmanova and Hoogenraad, 2005; Nakagawa et al., 
2000; Stepanova et al., 2003). Analysis was performed using LSM510 software, 
18 h post-transfection. N=16±5 growing microtubule plus-ends were counted 
per cell on microtubules that were visual on at least three consecutive frames. 
Statistical analysis was performed using the Student’s t-test. 
 
Results 
Eml4 expression is developmentally regulated 
We first determined the spatio-temporal expression pattern of Eml4 using ISH 
(Figure 2). Our results show that Eml4 is highly expressed in most regions in 
mouse E11 embryos. High expression levels are observed in developing 
nervous system, in fore- and hindbrain regions. Many other tissues also express 
Eml4. In E15 embryos, Eml4 is also highly expressed in the developing CNS (e.g. 
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neopallial cortex, ventricular zone, roof of midbrain, cerebellar primordium 
and spinal cord) and peripheral nervous system (e.g. ganglions).  
 
 
 
 
 
 
 
 
 
Other regions in which Eml4 is expressed include, liver, thymus, intestines, eye, 
kidney, salivary gland and paws. In E18 embryos, Eml4 expression is mainly 
restricted to regions of the developing nervous system e.g. in neopallial cortex 
(the future cerebral cortex), hippocampus, diencephalon, roof of midbrain, 
cerebellum and spinal cord. Expression of Eml4 is also observed within the 
developing intestine and eye.  
 
Because our results indicate that Eml4 expression is predominantly expressed 
within the developing nervous system, we performed ISH on brain sections of 
Figure 2. Developmental expression of Eml4. (A) At E11, Eml4 is expressed throughout the
whole embryo; (B) HE staining of E11 embryo. (C) Eml4 expression at E15 is more restricted to
the developing nervous system, the intestines and the eye; (D) HE staining of E15 embryo. (E)
At E18, Eml4 is expressed at lower levels compared with E11 and E15 embryos, and
expression is restricted to the intestines, the eye and the nervous system; (F) HE staining of
E18. (G–I) Non-radioactive ISH confirming Eml4 expression in E18 intestines (G), cerebellum
(H) and eye (I). 
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P1, P10 and adult mice (Figure 3). In P1 mouse brains, virtually all brain regions 
express Eml4. Highest expression levels are observed in cortex, olfactory bulb, 
hippocampus and cerebellum (data not shown). In P10 mouse brain Eml4 is 
expressed at lower levels compared with P1 mouse brain (data not shown). At 
this stage expression is mainly restricted to cortex, olfactory bulb, 
hippocampus and cerebellum (Figure 3A). In adult mouse brain Eml4 is 
expressed albeit at low level in olfactory bulb, hippocampus and cerebellum 
(Figure 3C). 
 
 
 
 
 
 
 
 
 
 
We confirmed the Eml4 expression pattern at all stages during development 
using an independent, digoxigenin-labeled cRNA probe (Figure 2G–I). The 
cellular resolution obtained with this technique indicates that in adult mouse 
olfactory bulb, the granule cell layer and mitral cell layer express Eml4 (Figure 
3G). In the hippocampus, the subventrical zone and the granule cell layers of 
Figure 3. Eml4 expression shown in P10 and adult mouse brain. (A) Eml4 expression in P10
sagital mouse slice, with expression in olfactory bulb, hippocampus, cortex and cerebellum.
(B) HE staining of the same slice as A. (C) Horizontal section of adult mouse brain, with Eml4
expression in olfactory bulb, hippocampus and cerebellum. (D) HE staining of slice in C. E, F
and G are non-radioactive ISH sections showing the cellular resolution of Eml4 expression of
adult mouse cerebellum (E), hippocampus (F) and olfactory bulb (G). ML, molecular layer;
PCL, Purkinje cell layer; GCL, granule cell layer; CA1, cornu ammonis 1; CA3, cornu ammonis
3; DG, dentate gyrus; MCL, mitral cell layer; EPL, external plexiform layer.  
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the dentate gyrus are labeled as well as the CA1-3 pyramidal cell layers of 
the Ammon’s horn (Figure 3F). In the cerebellum, Eml4 expression if found 
predominantly in the Purkinje cell layer (Figure 3E). Because the granule cell 
layers of the dentate gyrus, the mitral cell layer of the olfactory bulb, the 
Purkinje cell layer of the cerebellum and the CA1-3 pyramidal cell layers of 
the hippocampus predominantly contain cells of neuronal origin, our data 
indicate that Eml4 expression persists in postmitotic neurons. 
In summary, our ISH data indicate that Eml4 expression is highly 
developmentally regulated and that Eml4 expression becomes 
predominantly restricted to regions of the developing CNS. In addition, Eml4 
expression persists in adult mouse brain in neurons of olfactory bulb, 
hippocampus and cerebellum. 
 
Eml4 splice variants 
In order to determine the cellular function of Eml4, we cloned the full-length 
mouse Eml4 by RT-PCR using total RNA, isolated from adult mouse brain. The 
RT-PCR product was sequence verified, and was most similar to accession 
number AAH70427. However, we observed that our sequence (database 
accession number DQ230326) contained 174 additional base pairs suggesting 
that Eml4 may be subjected to alternative splicing. Furthermore other 
submitted Eml4 sequences (NM199466 and BC067011) also slightly differ in 
their primary sequence. When our sequence and the sequences AAH70427, 
NM199466 and BC067011 are plotted onto the mouse genome, it can be 
hypothesized that exons 2, 5, 6 and 8 are alternatively spliced. To confirm 
alternative splicing we performed RT-PCR on cDNA derived from E11, E15 and 
E18 embryos and different areas from adult mouse brain (olfactory bulb, 
cortex, hippocampus, cerebellum and brainstem). Indeed, RT-PCR on adult 
and developing mouse brain confirms that exons 5, 6 and 8 are subject to 
alternative splicing (Figure 4).  
 
 
 
 
Figure 4. RT-PCR on embryos and regions
of adult mouse brain. (A) RT-PCR using
exon 2 spanning primers. Our
experiments failed to identify expression
of this exon. (B) RT-PCR using primers
spanning exons 5 and 6 demonstrating
regulated splicing of exon 5/6 in adult
cerebellum. (C) Exon 8 is always present
in olfactory bulb, cerebellum and
brainstem. OB, olfactory bulb; Ctx,
cortex; Hip, Hippocampus; Cb,
cerebellum; BS, brainstem. 
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We were unable to confirm alternative splicing of exon 2. Although exons 5, 6 
and 8 are found at the examined developmental stages, the abundance of 
individual splice variants differs between specific brain areas. For example, 
adult cerebellum does not express an isoform with only exon 5 or exon 6.  
 
Protein expression of Eml4 
We performed Western blot analysis to examine specific Eml4 protein 
expression. To determine specificity of our antibody we first fused our Eml4 
construct C-terminally to eGFP (GFP-Eml4). We observed a distinct band at 
~150 kDa on Western blot of transiently transfected Cos7 cells (Figure 5A). 
Such size can be expected based on the molecular mass of the fusion 
construct: 120 kDa of Eml4+30 kDa of GFP. This band was recognized both by 
our Eml4 antibody (1139) and by an anti-eGFP antibody. However, this band 
was not detected in control, GFP transfected cells indicating that antibody 
1139 can recognize Eml4 fusion proteins. 
 
 
 
 
 
 
 
 
 
 
We next performed Western blot analysis of proteins isolated from whole E11 
embryos, E15 brain, E18 brain and adult olfactory bulb, cortex, cerebellum 
and hippocampus (Figure 5B). Our antibody recognized distinct bands 
around 120 kDa, molecular weights that correspond to the calculated mass 
of Eml4 (and splice variants). These bands were not recognized by pre-
immune serum (Figure 5B). Similar to RNA expression, the embryonic stages 
Figure 5. (A) Specificity of serum 1139 demonstrated by Western blot analysis. Anti-GFP 
antibodies recognize a distinct band of ~150 kDa denoted by the arrow in GFP-Eml4 
transfected Cos7 cells (lane 1) and a band of ~30 kDa in GFP-transfected cells (lane 2). 
These bands correspond to the calculated molecular weights of GFP-Eml4 and GFP 
respectively. Serum 1139 (lanes 3 and 4) recognizes a band identical to the band 
identified using GFP-antibodies in GFP-Eml4-transfected cells (lane 3). No specific band 
with this antibody was observed in control (GFP−) transfected cells. (B) Western blot 
analysis of E11, E15, E18 and various brain areas of adult mouse brain using serum 1139 
(left) and pre-immune serum (right). OB, olfactory bulb; Ctx, cortex; Hip, Hippocampus; 
Cb, cerebellum; BS, brainstem. 
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show higher Eml4-protein expression levels compared with adult brain regions. 
Western blot analysis therefore indicates that, Eml4 protein expression is 
developmentally regulated and expression persists in distinct regions of the 
adult mouse brain.  
 
Eml4 associates with and stabilizes microtubules 
We next transiently transfected GFP-Eml4 into Cos7 and HeLa cells in order to 
help elucidate the molecular function of Eml4. In non-dividing cells we 
observed a clear filamentous staining pattern radiating from a perinuclear 
region 18 h post-transfection. When the transfected cells were counterstained 
with anti-beta tubulin antibodies, we observed a complete colocalization of 
GFP-Eml4 with microtubules (Figure 6A). GFP-Eml4 staining can be observed 
throughout the whole microtubule. This colocalization suggests that Eml4, like 
its archetypical family member EMAP, is a MAP.  
 
 
 
 
 
 
 
 
 
As EMAP and Eml2 have been shown to associate with the mitotic spindle of 
dividing cells (Eichenmuller et al., 2002; Suprenant et al., 1993), we examined 
Figure 6. GFP-Eml4 transiently transfected into Cos7 cells. Transfected cells were visualized
by GFP fluorescence and cells were counterstained with a tubulin antibody (red). Right
panel shows merge. (A) Cos7 cells 18 h post-transfection shows radiating microtubules
that colocalize with GFP-Eml4 whereas circular microtubules are observed 48 h post-
transfection (B). Eighteen hours post-GFP-Eml4 transfection, transfected cells are resistant
to microtubule depolymerization by nocodazole for 20 min whereas in non-transfected
cells microtubules are disrupted (C).  
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whether GFP-Eml4 also colocalizes with microtubules of the mitotic spindle. 
Indeed, both in dividing Cos7 and HeLa cells, GFP-Eml4 shows a clear 
colocalization with the mitotic spindle (Figure 7). GFP-Eml4 staining appeared 
uniform across the spindle. We only observed colocalization with the mitotic 
spindle in cells expressing very low amounts of GFP-Eml4 (hence the relative 
high background staining in these cells). This may indicate that overexpression 
of GFP-Eml4 interferes with the process of cell division. We therefore quantified 
the dividing cell population following transient transfection. Mock transfected 
Cos7 cells have a dividing cell population of 4.65% ±1.03 whereas in GFP-Eml4 
transfected cell, this percentage is decreased to 1.44% ±0.5 (P<0.01 using a 
Student’s t-test). These results confirm the hypothesis that Eml4 overexpression 
interferes with the cell cycle.  
 
 
 
 
 
 
 
Apart from a colocalization of GFP-Eml4 with microtubules in non-dividing 
Cos7 and HeLa cells, we also observed that cells expressing GFP-Eml4 have 
microtubules with a circular appearance. These circular microtubules, a result 
of microtubule elongation or microtubule bundling, were observed either 18 h 
post-transfection in cells expressing high amounts of GFP-Eml4 (as determined 
by the relative fluorescence intensity) or 48 h post-transfection in cells 
expressing low amounts of GFP-Eml4 (Figure 6B). The observation that GFP-
Eml4 induces bundling or elongation of microtubules suggests that Eml4 
functions as a microtubule stabilizing protein. To confirm that Eml4 is a 
microtubule stabilizing protein, we investigated the effect of Eml4 
overexpression on microtubule stability following microtubule disruption. 
Eighteen hours following transient transfection with GFP-Eml4, Cos7 cells were 
treated with 10 µM nocodazole for 20 min. Under these conditions, virtually no 
polymerized microtubules were detectable in non-transfected cells. In 
Figure 7. GFP-Eml4 transiently transfected into HeLa cells. GFP-Eml4 colocalizes with
the mitotic spindle of dividing cells. Cells were counterstained with a tubulin antibody
(middle panel). In the right panel GFP-Em14 and tubulin signals are overlaid, showing
colocalization of GFP-Eml4 with the mitotic spindle. 
Eml4, a member of the EMAP family, stabilizes microtubules 
 
4 7  |  P a g e  
 
contrast, polymerized microtubules were readily detected in cells expressing 
GFP-Eml4 (Figure 6C). Because nocodazole is an effective microtubule-
disrupting agent, an Eml4-associated resistance to nocodazole-induced 
depolymerization indicates Eml4 functions as a microtubule stabilizing protein. 
In addition to nocodazole treatment, we measured the microtubule growth 
rate by monitoring the velocity of EB3-mRFP in transiently (co-)transfected 
Cos7 cells. In such experiments, microtubule-stabilizing proteins indirectly 
reduce the polymerization rate by reducing the concentration of non-
polymerized α- and β-tubulin dimers in the cytoplasm: The concentration of 
unbound tubulin dimers is rate limiting for microtubule polymerization. EB3 is a 
plus end-tracking protein (Akhmanova and Hoogenraad, 2005; Nakagawa et 
al., 2000; Stepanova et al., 2003) and therefore only associates with the tips of 
growing microtubules. For in vivo visualization, EB3 was fused to a mRFP. Cos7 
cells, transiently transfected with EB3-mRFP only, showed an average 
microtubule growth rate of 0.36 µm/s (range: 0.26–0.5 µm/s, n=200 
microtubule plus-ends) as measured by the speed of movement of EB3-mRFP 
comet-like dashes (1 frame/s) (Figure 8). Others have reported similar 
microtubule growth rates. Interestingly, the microtubule growth rate in the 
presence of GFP-Eml4 decreases significantly (P<0.01) to 0.27 µm/s (range: 
0.16–0.4 µm/s; n=200 microtubule plus-ends). This Eml4-associated decrease in 
microtubule growth was observed in three independent experiments, with 
analysis performed blind to the experimenter. In summary, GFP-Eml4 
expression is associated with a decrease in microtubule growth rate and this 
decreased growth rate is in line with the hypothesis that GFP-Eml4 stabilizes 
microtubules. 
 
 
 
 
 
 
Figure 8. GFP-Eml4 cotransfection decreases microtubule growth rate. (A) Microtubule
growth rate decreases significantly in the presence of Eml4. (B) EB3-mRFP (in white)
comet-like structure in six successive frames, 1 s interval. The traveled distance of the
comet-like structure is 2 µm whereas in the presence of Eml4 the traveled distance of the
comet-like structure is 1.4 µm. 
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Discussion 
Expression of Eml4 
Our ISH experiments demonstrate that Eml4 is highly expressed in E11 mouse 
embryos and expression declines throughout development. In addition, Eml4 
expression becomes restricted during maturation to the CNS, eyes and 
intestines. Although Eml4 is highly expressed in developing embryos, our results 
indicate that Eml4 expression persists in the adult olfactory bulb, 
hippocampus and cerebellum. This spatio-temporal expression pattern is 
confirmed on the protein level by Western blot analysis. The developmentally 
regulated expression of Eml4 was also confirmed in a different study using 
differential display (Thuret et al., 2004): Eml4 is differentially expressed 
between early embryos (E12, E14) and the adult olfactory bulb. Although the 
developmentally regulated expression of Eml4 is unique among other 
mammalian members of the EMAP protein family (O'Connor et al., 2004) (S.H. 
Houtman, unpublished observations), other MAPs have also been reported to 
show developmentally regulated expression. These include mouse neuron 
navigator (mNAV) (unc-53 (uncoordinated 53)) (Martinez-Lopez et al., 2005) 
and doublecortin (Francis et al., 1999; Gleeson et al., 1999). 
 
Eml4 is a member of the EMAP protein family 
Our study required cloning the full length cDNA sequence of Eml4 from adult 
mouse brain. In comparison to mouse Eml4 sequences from the public 
databases (AAH70427, BC067011 and NP__199466) we identified an extra 
exon (exon 5) that is included in several Eml4 transcripts. Because adult 
cerebellum only expresses a distinct subset of splice-variants, our results 
provide evidence for tissue specific alternative splicing. We were unable to 
confirm splicing of exon 2 in any of our experiments; exon 2 was absent in all 
transcripts. Transcripts containing exon 2 are therefore expressed either at 
very low levels or expressed in areas not examined in this study. On the protein 
level, these splice variants do not affect the Eml4 domain structure. However, 
transcripts that include exon 2 do disrupt a previously unidentified alpha-
helical coiled-coil (a putative dimerization domain (Lupas et al., 1991; Mason 
and Arndt, 2004; O'Connor et al., 2004)). This coiled-coil is also present in the 
public domain database entry of Eml4 (Heidebrecht et al., 2000). Such 
dimerization domain has been identified in several other members of the 
EMAP protein family (O'Connor et al., 2004). We therefore screened for and 
identified coiled-coil domains in all mammalian EMAP protein family 
members. Because alpha-helical coiled-coil domains are putative 
dimerization domains, it is possible that Eml4 forms either homodimers or 
heterodimers with other Eml family members. The expression of multiple Eml4 
transcripts may result in a number of Eml4 proteins with differences in 
Eml4, a member of the EMAP family, stabilizes microtubules 
 
4 9  |  P a g e  
 
molecular mass. Indeed, Western blot analysis identified multiple bands 
around the calculated molecular mass of Eml4 (120 kDa). 
 
Microtubule association of Eml4 
Our results demonstrated that GFP-Eml4 co-localizes with the microtubules of 
non-dividing cells. Eml4 is therefore likely to be a MAP. This hypothesis is 
supported by recently performed co-sedimentation assays (Pollmann et al., 
2006). Furthermore GFP-Eml4 co-localizes with the entire microtubules of non-
dividing cells and therefore is neither a plus-end binding, like cytoplasmic 
linker proteins 170 kDa (Clip-170), EB1 or EB3 (Akhmanova and Hoogenraad, 
2005; Perez et al., 1999; Stepanova et al., 2003; Tirnauer and Bierer, 2000), nor 
a minus-end binding protein. 
In addition, we also showed that GFP-Eml4 colocalizes with the mitotic spindle 
of dividing cells. Such colocalization to the mitotic spindle has also been 
reported for other members of the EMAP protein family e.g. EMAP (Suprenant 
et al., 1993) and Eml2 (Eichenmuller et al., 2002) as well as for human EML4 
(Pollmann et al., 2006). The observation that Eml4 colocalizes with the mitotic 
spindle therefore renders Eml4 likely to play a role during cell division. This 
hypothesis is supported by our observation that the mitotic index of GPF-Eml4 
expressing cells is reduced and the observation that down-regulation of EML4 
in HeLa cells affects cell proliferation (Pollmann et al., 2006). Similar to EMAP 
(Brisch et al., 1996), the function of Eml4 may be determined in a 
phosphorylation dependent manner during cell cycle (Pollmann et al., 2006). 
 
Eml4 is a microtubule stabilizing protein 
In our transient transfection experiments, we observed circular microtubules 
18 h post-transfection in cells that express GFP-Eml4 at a high level and in 
virtually all cells 48 h post-transfection. These circular microtubules may be a 
result of microtubule bundling or microtubule elongation and are suggestive 
of a microtubule stabilizing function of Eml4. This stabilizing function of Eml4 
was confirmed in nocodazole-induced microtubule depolymerization 
experiment. Cos7 cells transiently transfected with GFP-Eml4 were resistant to 
nocodazole induced microtubule disruption. 
In a separate set of experiments we demonstrated that the microtubule 
growth rate is significantly decreased in cells expressing GFP-Eml4. Because 
the concentration of unbound tubulin dimers is rate limiting for microtubule 
polymerization, overexpression of microtubule-stabilizing proteins indirectly will 
reduce the polymerization rate due to a reduction in the cytoplasmic 
concentration of non-polymerized α- and β-tubulin dimers. The reduced Eml4-
associated microtubule growth rate therefore confirms the hypothesis that 
Eml4 is a microtubule stabilizing protein. Interestingly, other members of the 
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EMAP protein family, Eml2 and EMAP, have been shown to destabilize 
microtubule. For example, Eml2 reduces growth rate and increases the 
frequency of catastrophe (the transition from growing to shortening 
microtubules) (Eichenmuller et al., 2002), whereas EMAP destabilizes 
microtubules by reducing the frequency of rescue (the transition from 
shortening to growing microtubules) (Hamill et al.). Eml4 is therefore the first 
member of the EMAP protein family that stabilizes microtubules. Our results 
were confirmed in an independent study demonstrating EML4 is essential for 
microtubule formation (Pollmann et al., 2006). How Eml4 stabilizes 
microtubules (reduction in catastrophe rate, reduction in shrinkage rate, 
increase in rescue frequency, increase in growth rate) requires further 
investigation by e.g. in vitro polymerization assays. 
 
The role of Eml4 in postmitotic neurons 
Our results indicate that Eml4 is highly expressed in the developing nervous 
system and expression persists in discrete regions of the adult mouse brain. 
Recently a study by Dunckley and Lukas (2003) describes Eml4 (C2ORF2) as 
one of the genes that are down-regulated by nicotine stimulation of a 
neuroblastoma cell line. This nicotine-regulated expression argues for role of 
Eml4 following increased neuronal activity. 
Although the exact cellular function of Eml4 in postmitotic neurons remains to 
be determined, protein–protein interactions of other closely related proteins 
(i.e. other members of the EMAP protein family) might help defining the 
cellular function of Eml4. For example, members of the Eml family are shown 
to interact with δ1- and δ2-glutamate receptor (Eml2) and with 14-3-3 (Eml3) 
(Jin et al., 2004; Ly et al., 2002; Pozuelo Rubio et al., 2004). The δ1- and δ2-
glutamate receptors are members of a distinct protein family (Lomeli et al., 
1993) of which the δ2-glutamate receptor expression is restricted to cerebellar 
Purkinje cells (Takayama et al., 1996; Yuzaki, 2003). Although Eml2 can interact 
with the δ2-glutamate receptor, it appears not to be expressed in these cells. 
Interestingly, the δ2-binding site of rat Eml2 shares a 75% similarity and 58% 
identity to the homologous region of mouse Eml4. Because of this high degree 
of homology between the δ2-binding site and because our results indicate 
that Eml4 is expressed in adult cerebellar Purkinje cells, it is tempting to 
speculate that the natural binding partner of δ2-glutamate receptor is Eml4. 
However, a direct association between Eml4 and δ2-glutamate receptor 
remains to be determined. The 14-3-3 proteins, although initially found in brain, 
are ubiquitously expressed and form a family of proteins that are involved in 
diverse cellular processes including regulation of cell cycle, signal 
transduction pathways and differentiation (Mackintosh, 2004; Mhawech, 
2005; Muslin et al., 1996). Because of the high degree of homology between 
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Eml3 and Eml4, it is possible that 14-3-3 proteins interact with Eml4 and/or 
other members of the EMAP protein family. Although such interactions and 
cellular functions remain to be examined, our study is the first to determine 
that Eml4 is a developmentally regulated protein that associates with and 
stabilizes microtubules.  
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Abstract 
We have isolated a novel transcript with homology to the major microtubule-
associated protein in dividing sea urchin embryos, EMAP. The protein has a 
predicted MW of ~180 kDa and we have named it Eml5 (EMAP-like protein 5, 
GenBank accession no. AY445136). Eml5 contains 11 putative WD40 domains 
and 3 hydrophobic stretches of 43 aa, HELP domains, which have been 
suggested to be involved in microtubule binding. Eml5 appears to consist of 
two tandem repeats of the complete EMAP protein separated by a putative 
dimerization domain. Eml5 mRNA and protein is expressed at high levels in the 
hippocampus, cerebellum and olfactory bulb, as determined by in situ 
hybridization and immunocytochemistry. Eml5 transcripts can be detected in 
fore- and hindbrain structures from embryonic day 13 onwards. Because other 
EMAP-like proteins are involved in regulating microtubule dynamics, it is likely 
that Eml5 plays a role in the regulation of cytoskeletal rearrangements during 
neuronal development and in adult brain  
 
Introduction 
Microtubules are polymers made up of α- and β-tubulin subunits that provide 
architectural support for eukaryotic cells. In neurons, they are required for the 
growth and maintenance of neuronal processes (Sanchez et al., 2000). 
Furthermore, microtubules act as pathways for transport of cytoplasmic 
constituents. Microtubules have an intrinsic polarity with a slow growing minus 
end and a fast growing plus end. In most cells, microtubules are anchored to 
the major microtubule-nucleating center, the centrosome (Bornens, 2002), 
and are oriented with their plus ends distal to the cell body (Joshi, 1998). In 
neurons, the microtubular network is arranged slightly different; microtubules 
are not anchored to the centrosome and, in dendrites, are oriented in both 
directions (Baas, 1999). Axonal microtubules, however, are oriented with their 
plus ends away from the soma (Heidemann et al., 1981). It has been 
hypothesized that microtubules in neuronal processes may be established by 
mechanisms similar to those used for the formation and functioning of the 
mitotic spindle (Baas, 1999), which, during mitosis, become the key structural 
components on which chromosomes segregate. 
Structural binding proteins control the dynamics of microtubules by regulating 
the growth and shrinkage at the plus ends (Walczak, 2000). Microtubule-
stabilizing proteins like MAP2 (Sanchez et al., 2000) and Tau (Buee et al., 2000) 
promote growth by, for example, reducing the rate of catastrophe (the 
transition from growing to shrinking). Microtubule-destabilizing proteins like 
Op18/stathmin (Cassimeris, 2002) promote microtubule disassembly, or, like 
katanin, even cause severing of microtubules (Ahmad et al., 1999). 
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In dividing sea urchin (Strongylocentrotus purpuratus) eggs, a 77-kDa 
echinoderm microtubule-associated protein (EMAP) is the major microtubule-
binding protein (Hamill et al., 1998; Suprenant et al., 1993). Several 
mammalian homologues of EMAP, EMLs (EMAP-like proteins), have been 
identified. They include the Human homologue of EMAP isolated from the 
Usher-1a locus, EML1 (Eudy et al., 1997), EML2/Huemap2 (Lepley et al., 1999), 
and EML4/ROPP120 (Heidebrecht et al., 2000). An additional EML, EML3, can 
be predicted from the human genomic sequence. Several EMLs have been 
demonstrated to associate with microtubules of the mitotic spindle in vivo 
and in vitro (Eichenmuller et al., 2002; Hamill et al., 1998; Suprenant et al., 
1993). Furthermore, EML proteins appear to affect the dynamics of 
microtubules. For example, EMAP increases microtubule dynamics and inhibits 
the frequency of rescue (the transition from shortening to growing 
microtubules; Hamill et al., 1998), whereas EML2 reduces the growth rate and 
promotes the frequency of catastrophes (the transition from growing to 
shortening; Eichenmuller et al., 2002). Because both EMAP and EML2 
effectively cause an overall shortening of microtubules, the EML family of 
proteins may represent a novel class of microtubule-destabilizing proteins. 
Here we report the cloning and characterization of a fifth member of the EML 
family, Eml5 and splice variants Eml5a and Eml5b. Because Eml5 is expressed in 
post-mitotic neurons (in adult animals and during development), we 
hypothesize that Eml proteins play a role in the cytoskeletal rearrangements 
observed during neuronal development and in adult brain. 
 
Materials and Methods 
Differential display 
Differential display performed primarily to identify genes regulated in LTP also 
identified a number of candidates whose expression and/or sequence 
homology warranted further investigation. The PCR-based methods used to 
generate fragments of hippocampal cDNA were as described previously 
(French et al., 2001). The fragment of Eml5 described in this study was 
amplified using the primer combination ACGACTCACTATAGGGC(T)12AC and 
ACAATTTCACACAGGATGGATTGGTC. 
 
In situ hybridization 
Brains from adult rats were removed, frozen on dry ice and stored at −70 °C. 
Fourteen-micrometer sections were cut on a cryostat, mounted onto 
polylysine-coated glass slides and stored at −70 °C. In situ hybridization was 
performed essentially as described by French et al. (2001). Briefly, sections 
were thawed, fixed in 4% paraformaldehyde, acetylated in 1.4% 
triethanolamine and 0.25% acetic anhydride, dehydrated through graded 
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ethanol solutions and delipidated in chloroform. Sections were hybridized 
overnight at 42 °C in 100 µl buffer containing 50% formamide, 4× SSC, 10% 
dextran sulfate, 5× Denhardt's solution, 200 mg/ml acid alkali cleaved salmon 
testis DNA, 100 mg/ml long-chain polyadenylic acid, 25mM sodium 
phosphate (pH 7.0), 1 mM sodium pyrophosphate and 100,000 CPM 
radiolabeled probe (approximately 1 ng/ml) under parafilm coverslips. 
Sections were washed in 1× SSC at 55 °C (30 min), 0.1× SSC at room 
temperature (5 min) and dehydrated in ethanol. Sections were then exposed 
to autoradiographic film. 35S-ATP end-labeled probes (NEN) were generated 
using terminal deoxynucleotidyl transferase (Promega) according to 
manufacturer's instructions. Either a 50-fold excess of unlabeled antisense 
oligonucleotide or the complementary sense oligonucleotide was used as 
negative controls. 45-mer oligonucleotides of unique sequence were supplied 
by Oswel (Southampton, UK) or Life Technologies. Sequences were: Eml5 
antisense I (corresponding to aa 470–484): CTTTCCTCCTGGCATCTTGTAGAGAAG 
TCGTTTCCCACTGCCGTC and II (corresponding to aa 1334–1348): 
TGGGCGGATATTAGTTGATAAGGCTCTGATGGTGTAGCTAATTTC, and Eml5b splice 
variant: CCCCTGTAGCTAGGACCATTTTGTCACTCCACACTGGGGATGGTT. 
Control sense oligos are complementary to the antisense oligo. 
For nonradioactive in situ hybridizations, sections were fixed as described 
above, prehybridized (1 h) in buffer containing 50% formamide, 5× SSC, 5× 
Denhardt's, 250 µg/ml yeast tRNA (Sigma) and 500 µg/ml acid–alkali cleaved 
salmon testis DNA (Sigma). Hybridization was performed overnight at 65 °C in 
prehybridization buffer containing 100 ng/ml digoxigenin-UTP labeled cRNA 
probes. Antisense and sense probes directed against bp 2929–4074 were 
generated using a DIG RNA labeling kit (Roche) according to manufacturer's 
instructions. Following hybridization, sections were washed in 0.2× SSC at 65 °C 
and blocked in 0.1M Tris pH 7.5, 0.15M NaCl and 10% heat inactivated sheep 
serum (Sigma) for 1 h at RT. Alkaline phosphatase conjugated anti-
digoxigenin antibodies (Roche) were added to the sections in a dilution of 
1:5000 in 0.1M Tris pH 7.5, 0.15M NaCl and 1% heat-inactivated sheep serum 
and incubated overnight at 4 °C. Following washing of the sections, color 
reactions were performed in 0.1 M Tris pH 9.5, 0.1 M NaCl, 50 mM MgCl2, 2 mM 
Levamisole (Sigma), 0.35 mg/ml nitroblue tetrazolium (Roche) and 0.18 mg/ml 
5-bromo-4-chloro-3-indolylphosphate (Roche). Reactions were terminated 
upon visual inspection (~18 h), counterstained in 0.1% Fast red, dehydrated 
and mounted in Permount (Fisher). 
 
RT-PCR 
Rat hippocampal RNA was extracted using Trizol (Invitrogen) and reverse 
transcribed into cDNA using SuperscriptIII (Invitrogen). To determine the 
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relative abundance of individual splice variants, the following PCR primers 
were used: Splice site 1: GTGTCCTTTCACCACAGAAAAG (fwd) and 
CCACTTCACTTGTCCATACC (rev). Splice site 2: GCCTTATCAACTAATATCCGCC 
(fwd) and CCAACACAAGGTCCTCTATG (rev). 
 
Antibodies 
A fragment of Eml5 cDNA encoding aa 468–664 was fused to a His tag using a 
pET30b (Novagen) plasmid. The Eml5 fusion protein was expressed in bacteria 
(BL21dP lys S, Stratagene) and purified under denaturing conditions over Ni-
NTA columns (Qiagen) according to manufacturer's instructions. Adult New 
Zealand White rabbits were immunized with 80 µg of purified Eml5468–664 using 
Freund's complete adjuvant. The immunization was followed by four boosts of 
80 µg Eml5468–664 administered every 3 weeks in Freund's incomplete adjuvant. 
Serum was collected from bleeds taken 7 days after each boost; serum from 
boost 3 and 4 were used in this study. Antibodies were affinity-purified over 
nitrocellulose filter strips containing immobilized His tagged Eml5468–664 
(transferred by Western blotting following SDS-PAGE of the affinity purified 
fusion protein). Bound antisera were eluted from the filter using 0.1 M glycine 
(pH2.3) and 1 M NaCl. After elution, the pH was quickly restored with 
unbuffered 1 M Tris. 
 
Immunocytochemistry 
Rats were perfused transcardially with a 4% paraformaldehyde solution in PBS. 
Brains were removed and stored in a 20% sucrose solution. Forty-micrometer-
thick coronal sections were cut and washed in 0.1 M phosphate buffer (PB), 
incubated in 2% hydrogen peroxide in 0.1 M PB for 30 min and washed in PB. 
Sections were then incubated for 72 h with affinity-purified rabbit polyclonal 
Eml5 antibodies at a dilution of 1:100 in PB, 0.3% Triton and 3% normal goat 
serum (NGS). Next, sections were washed in PB and incubated with a 
biotinylated goat antirabbit antibody (Vector) at a dilution of 1:500 for 1 h. 
Sections were then incubated for 30 min in Advance Vector ABC Elite 0.02% in 
PB. Staining was performed using hydrogen peroxide (0.01–01%) in 0.15 M Tris 
(pH 7.4) containing 0.5 mg/ml DAB and 2 mg/ml ammonium nickel sulfate. 
Staining reactions were terminated upon visual inspection. 
2.6. Cell culture 
Cos7 cells, grown in Lab-Tek chamber slides, were transfected using DEAE-
dextran. In brief, cells were incubated for 30 s in serum-free medium 
containing 0.5 mg/ml DEAE-dextran. Cells were then exposed to a Eml5b 
construct C-terminally fused to GFP (1 µg) in the presence of 0.1 mM 
chloroquine for 5–6 h. The Eml5b construct was generated by PCR 
amplification using primers AGCGGGAGAGCTTTCGTCAC (fwd) and 
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CTTTAGCACCAGTGTTGACC (rev) on constructs that were derived from library 
screens and RT-PCR reactions. Finally, cells were incubated in 10% DMSO after 
which they were returned to normal medium [10% fetal calf serum, 45% DMEM 
and 45% F-10 supplemented by antibiotics (penicillin and streptomycin)]. 
Eighteen to forty-eight hours after transfection, cells were fixed in ice-cold 
methanol (100%), 1 mM EGTA (10 min) and subsequently in 4% 
paraformaldehyde (10 min). Cells were permeabilized in 0.1% Saponin/PBS, 
containing 1% BSA, 10% fetal calf serum before being incubated (1 h) with 
anti-Eml5 antibodies (1:200). Following washing in PBS, cells were incubated (1 
h) with the secondary antibody (Alexa-Fluor goat anti rabbit 594, dilution 
1:300). Slides were mounted in Vectashield mounting medium (Vector 
Laboratories) containing DAPI. 
 
Northern blot analysis 
Partial Eml5 sequence corresponding to bp 1764–2052 (amino acids 458–553), 
isolated as a candidate LTP regulated gene from the differential display 
screen was used to generate radiolabeled double-stranded cDNA probes 
(Prime-It II Random Primer Labeling Kit, Stratagene) to screen both a 
hippocampal library and a rat brain Northern blot (Origene). Northern blots 
were prehybridized in 5× SSPE, 1% SDS, 5× Denhardt's and 0.1 mg/ml Salmon 
testis DNA (Sigma) for 3 h, and then, hybridized overnight in buffer containing 
5× SSPE, 0.2% SDS, 5× Denhardt's, 0.1 mg/ml Salmon testis DNA (Sigma), 50% 
formamide and 0.8 106 cpm/ml probe at 68 °C. Blots were subsequently 
washed in 2× SSC, 0.05% SDS for 40 min at room temperature, and 0.1× SSC, 
0.1% SDS at 50 °C. Blots were then exposed to X-ray film. Equivalent loading 
between tissues was determined by rehybridizing the blot with a 1.3-kb 
fragment at the 3′ end of KIAA0828, a 5.1-kb mRNA transcript expressed at 
high levels throughout the brain (Nagase et al., 1998). 
 
Library screen 
cDNA encompassing the 3′ 3.2 kb of Eml5 was obtained by RACE-PCR 
(marathon cDNA amplification, Clontech) on mRNA isolated from rat 
cerebellum, hippocampus and olfactory bulb using oligonucleotides 
CAACACACGTCCATGAAGCCCAG and AAATGACGGCAGTGGGAAACGAC 
(corresponding to aa 497–503 and 469–475, respectively). RACE-PCR 
fragments were independently sequence verified following RT-PCR using 
primers GGTTGGTTTAGAGATCCTCAATTCAC and CCTCATTCACTTTCTGCCACTCC. 
The full-length Eml5 sequence was obtained by screening a rat hippocampal 
library that had undergone one round of amplification (a generous gift from 
N. Galjart, C.I. De Zeeuw and F. Grosveld). Duplicate filters containing ~106 
clones were hybridized overnight at 60 °C with 106 CPM/ml hybmix (5× SSC, 5× 
Chapter 3 
 
6 2  |  P a g e  
 
Denhardt's, 0.1% SDS, 100 µg/ml salmon testis DNA). Then, filters were washed 
at 60 °C in 2× SSC, 0.1% SDS and 0.1× SSC, 0.1% SDS. Five double-positive 
plaques were identified and were replated and screened to obtain single 
purified plaques. Purified plaques were subjected to in vivo excision 
according to the manufacturer's instructions (Stratagene). This identified the 
additional 2.8 kb situated at the 5′ end of Eml5. 
 
Results 
Cloning and sequence analysis of rat Eml5 
Partial Eml5 corresponding to bp 1764–2052 (amino acids 458–553) was 
isolated as a false positive from a screen primarily aimed at identifying genes 
induced 24 h following the induction of LTP in the dentate gyrus of the 
hippocampus. The full-length sequence was cloned by a combination of 
screening a hippocampal library and 5′ and 3′ RACE PCR (GenBank 
accession no. AY445136). Within the sequence, a single large open reading 
frame was detected that encompasses a protein of 1606 amino acids with an 
estimated molecular mass of ~180 kDa. Stop codons can be found in all 
reading frames before the putative rat Eml5 translation initiation site, 
suggesting we indeed cloned the full-length rat Eml5 cDNA sequence. A 
consensus Kozak sequence (Kozak, 1987) can be identified around the 
putative translation initiation site. 
The protein encoded by the cDNA revealed a marked homology to the 77-
kDa echinoderm microtubule associated protein (EMAP) of which three other 
mammalian homologues have thus far been identified. A fourth homologue 
can be predicted from the human genomic sequence. We have therefore 
named this protein EMAP like protein 5 (Eml5), the largest member of the Eml 
family. Figure 1A shows the homology of Eml5 with the other family members. 
Because Eml5 appears to consist of a 2.5-fold repeat of the complete EMAP 
protein, we have aligned the N-terminal, middle and C-terminal parts 
separately. This repeat is highlighted by the similarity between individual parts 
of Eml5; the middle part (aa 674–1270) has 42% identity and 64% similarity with 
amino acids (aa) 7–599 of the N-terminal part. The homology of Eml5 to EMAP 
is equal at both ends of the protein; both the N-terminus (aa 7–594) and 
middle part (aa 674–1270) exhibit 34% identity and 53% similarity to EMAP. A 
phylogenetic analysis of the EML family is depicted in Figure 1B, and shows 
that Eml5 is more closely related to EMAP than to other members of the Eml 
family.  
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A schematic representation of domains present within Eml5 is shown in Figure 
1C. Like other members of the EMAP family, Eml5 contains several (11) 
putative WD40 domains as well as three consensus HELP domains 
(hydrophobic EMAP-like protein domain), domains that may be required for 
microtubule binding (Eichenmuller et al., 2002). A region that is strongly 
predicted to contain an alpha-helical coil, a putative dimerization domain, 
separates the N-terminal and middle part of Eml5 (aa 641–673). 
Eml4/ROPP120 and the predicted sequence of Eml3 are other family 
members that also contain such putative dimerization domain. Several 
potential sites for protein kinases can be identified within the Eml5 sequence. 
Although consensus phosphorylation sites have a high probability of 
occurrence within any given sequence, conservation of sites in all EML family 
members may be an indicator of functional relevance. However, none of the 
consensus sites for protein kinase A, cGMP-dependent protein kinase and 
protein kinase C appears to be conserved in all EML proteins. Besides the 
features mentioned, Eml5 is unique among the EML family in that it is the only 
member that lacks a consensus site for an EF hand, a calcium-binding 
domain. 
A sequence homologous to EML can be found on chromosome 14q31 of the 
completed human genome (LOC161436). The coding sequence of EML5 
described here is distributed over 33 exons, the translation–initiation site being 
within exon 1, and spans over 165 kb of genomic sequence. The predicted 
initiation site of human EML5 lies at a similar site to rat Eml5 supporting the 
assumption that we obtained the complete 5′ coding sequence of the 
mRNA. 
Figure 1. (A) Primary structure and
sequence homologies of Eml5.
The figure shows an alignment of
the N-terminal middle and C-
terminal parts of rat Eml5 with
EMAP (derived from S. purpuratus)
and human EML protein family
members EML1/HuEMAP1,
EML2/HuEmap2, EML3 (predicted)
and EML4/ROPP120. (B)
Phylogenetic analysis of the EML
protein family. (C) Schematic
drawing of EML proteins showing
location of HELP- and WD40
domains, EF hands and alpha
helical coiled coil region. 
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Eml5 splice variants 
Two alternative splicing products were also identified upon cloning the full-
length Eml5 sequence (Figure 2). Insertions of 110 and 56 bp at position 3891 
and 4397 (corresponding to aa 1166 and 1335), respectively. Omission at 
splice site 1 and insertion at splice sites 2 results in an insertion of an in-frame 
stop codon and gives rise to Eml5b and Eml5a, respectively. Comparison of 
the cDNA sequence with the human genome sequence revealed the first 
splice variant is likely to be caused by an alternative splice acceptor site 
within the 25th exon. The second variant is likely to be caused by insertion of 
an additional exon between exon 27 and 28. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Alternative splicing of Eml5 leads to the formation of Eml5a and Eml5b. (A) Location
of splice sites relative to the full-length Eml5 protein. Dashed lines indicate the individual
clones isolated from the differential display screen (DD), RACE-PCR (RC), RT-PCR (RT) and
library screens (LS). (B) Model of splice variants' origin based on comparison with the
completed human genome sequence. Eml5b is likely to be generated by an alternative
splice acceptor site whereas Eml5a is likely to be generated by insertion of an additional
exon. (C) RT-PCR showing relative expression levels of Eml splice variants. Expected and
identified PCR fragments are indicated with arrows. At splice site 1 (left panel), the expected
fragment size is 583 and 473 bp for Eml5/Eml5a and Eml5b, respectively. In situ hybridization
shows Eml5b expression in adult brain confirming expression of this splice variant. Expected
fragments at splice site 2 (right panel) are 251 and 191 bp for Eml5a and Eml5, respectively.
cb: cerebellum, ob: olfactory bulb, ctx: cortex, hip: hippocampus. 
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The largest continuous open reading frame as shown in Figure 1A (Eml5) 
therefore uses the first splice acceptor site at exon 25 and does not contain 
the insertion at the second splice site. The shortest isoform truncates the 
protein at position 1167 resulting in a protein with a predicted MW of 130 kDa. 
The other isoform results in a protein of 1367 aa with a predicted MW of 150 
kDa. We next performed RT-PCR to estimate the relative levels of all identified 
Eml5 splice variants. Our results show that all splice variants can be detected 
by RT-PCR, and that the ratio of expression between Eml5b and Eml5/Eml5a is 
estimated at 1:20. At splice site 2, the ratio of expression levels between Eml5a 
and Eml5 is estimated to be 1:2. All brain regions tested express both splice 
variants as determined by RT-PCR (depicted for splice site 2 in Figure 2C, data 
not shown for splice site 1). Although the use of the alternative splice 
sequence at splice site 1 (resulting in Eml5b) can be detected using RT-PCR, 
this transcript is expressed at low levels and we therefore performed in situ 
hybridization as an alternative approach to verify its expression. As can be 
seen in Figure 2C, in situ hybridization confirmed our RT-PCR data that 
demonstrated that Eml5b is expressed in cerebellum, hippocampus, cortex 
and olfactory bulb. Eml5b is expressed in brain regions similar to those that 
express Eml5 (see Figure 4). 
 
Eml5 mRNA and protein expression 
Northern blot analysis revealed that Eml5 is expressed in most regions of the 
adult rat brain (Figure 3). Highest levels of expression are found in 
hippocampus and olfactory bulb, moderate levels in the enthorinal cortex. 
No expression of Eml5 was detected in the striatum. Three distinct bands at 
~6.0, 8.0 and 12 kb were detected; the smallest corresponds to the length of 
the complete cloned Eml5 sequence described in this paper. Because, on 
the DNA level, no other sequences homologous to Eml5 can be found in the 
public domain databases, it is likely that the three bands are products 
derived from a single gene. It is possible that the splice variants shown in 
Figure 2 are the cause of the three transcripts detected on the Northern blot. 
However, these splice variants result from small (<120 bp) modifications. 
Therefore, for these splice variants to give rise to up to 4 kb differences in 
transcript size, they would also have to differ in the untranslated region. 
KIAA0828, a 5.1-kb mRNA transcript expressed at high levels throughout the 
brain (Nagase et al., 1998), was used as loading control.  
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In situ hybridization confirmed the expression pattern detected by Northern 
blot analysis. It revealed Eml5 is expressed at high levels in the cerebellum, 
olfactory bulb and the dentate gyrus of the hippocampus. Transcripts are also 
detected in the cortex and in the CA1 and CA3 regions of the hippocampus 
(Figure 4). The high levels of expression in the cerebellum, olfactory bulb and 
dentate gyrus may reflect the high density of cells in these regions. To 
estimate relative expression levels between individual neurons, we performed 
a nonradioactive in situ hybridization using digoxigenin-labeled cRNA probes. 
Although this method is less quantitative than radioactive-labeled probes, 
staining intensity within one section is related to the mRNA expression level. 
Using this method, we find that the cells with highest Eml5 expression are the 
Purkinje neurons of the cerebellum. Bearing in mind the quantitative limitations 
of this technique, a similar staining intensity was found in cortical neurons, CA1 
pyramidal cells, granule cells of the cerebellum and thalamic neurons. 
Intermediate Eml5 expression levels are found in granule cells of the dentate 
gyrus. No specific staining was observed using the sense (control) probe.  
 
During development, Eml5 transcripts are detected as early as embryonic 
day 13, E13 (Figure 5A), where they are expressed in regions of the 
developing brain. At E17, Eml5 is expressed in most regions of the developing 
brain as well as the developing kidney (Figure 5B). At this stage, transcripts are 
also detected in regions surrounding the intestine, consistent with Eml5 
expression in the enteric nervous system. At postnatal day 1 and 10, P1 and 
P10, Eml5 is expressed in most regions of the developing brain (Figure 5C,D). 
All in situ data presented were generated using oligo I but identical expression 
patterns were observed using the independent oligonucleotide II (data not 
shown). No hybridization signal was detected using either the sense probe or 
the antisense probe competed with a 50-fold excess of unlabeled oligo (not 
shown). 
Figure 3. Northern blot analysis of Eml5 expression in adult 
rat brain. Northern blot containing 20 µg total RNA 
extracted from distinct regions of brain. Highest levels of 
expression are detected in the olfactory bulb whereas 
hippocampus and enthorinal cortex show moderated 
levels of expression. Lower panel shows expression of 
equivalent loading as judged by KIAA0828, a 5.1-kb 
mRNA transcript expressed at high levels throughout the 
brain. 
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Figure 4. Eml5 expression in the adult rat brain. In situ hybridization on a sagittal section
(upper panel) demonstrating high levels of Eml5 expression in the olfactory bulb, cerebellum
and dentate gyrus region of the hippocampus. Transcripts are also detected in the cortex
and the CA1 and CA3 regions of the hippocampus. Lower panels show examples of
experiments using digoxigenin-labeled antisense cRNA probes to examine Eml5 expression
on a cellular level. Using this method, we find that the cells with highest Eml5 expression are
the Purkinje neurons of the cerebellum. Cortical neurons show a roughly similar staining
intensity compared to the CA1 pyramidal cells, granule cells of the cerebellum and thalamic
neurons. Intermediate Eml5 expression levels are found in the granule cells of the dentate
gyrus. 
Figure 5. Developmental expression of Eml5. (A) At E13, Eml5 is expressed in regions of the
developing brain. (B) At E17, Eml5 is expressed in most regions of the developing brain as well
as the developing kidney. At this stage, transcripts are also detected in regions surrounding
the intestine, consistent with Eml5 expression in the enteric nervous system. At (C) P1 and (D)
P10, Eml5 is expressed in most regions of the developing brain. 
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To examine Eml5 protein expression, we have generated antibodies directed 
against aa 469–674. This region, containing the putative dimerization domain, 
was chosen for its predicted antigenicity as well as its low homology to other 
EML family members. For example, the 206 aa antigenic protein has 25% 
identity and 41% similarity to EMAP over its entire region. We first characterized 
these antibodies on Cos-7 cells that were transiently transfected with an Eml5b 
construct C-terminally fused to GFP. As can be seen in Figure 6B, transient 
transfection of the Eml5b-GFP construct shows an antibody staining pattern 
that is virtually identical to the GFP signal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Distribution of Eml5 protein in neurons. (A) Immunocytochemistry using antibodies
directed against Eml5468–664 shows Eml5 immunoreactivity in the rat brain. Virtually no signal
is detected using antibody preabsorbed with Eml5468–664 protein (upper panel) compared
to the immune serum (lower panel). (B) Specificity of the antibody was confirmed in Cos7
cells transfected with an Eml5b-GFP construct. Transfected cells were visualized by GFP
fluorescence (GFP) and were counterstained with our Eml5 antibody (α-Eml5). Overlay
(merge) shows an identical staining between GFP and anti-Eml5 stained cells and
demonstrates the specificity of the antibody. Nontransfected cells, visualized by the DAPI
nuclear stain (blue signal) show no detectable Eml5-antibody signal. (C) In the
cerebellum, Eml5 expression can be observed in the granule cells, the molecular layer
and in Purkinje cells. Because the molecular layer receives axonal and dendritic
projections from granule cells and Purkinje cells, respectively, Eml5 expression may not be
restricted to either subtype of cellular process. (D) Eml5 immunoreactivity can also be
observed in the hippocampus in all major cell layers and projection areas. No specific
staining was observed when the antibodies have been competed with antigen
(preabsorbed). 
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The fact that our antibodies recognize the Eml5 protein was further 
demonstrated by the fact that no specific staining was observed on rat brain 
sections incubated with preimmune serum (not shown) or with Eml5 
antibodies preabsorbed on immobilized antigen (Figure 6A,C,D). These 
experiments demonstrate that our antibodies recognizes the Eml5 protein. 
Immunocytochemistry using these antibodies revealed that presumptive Eml5 
expression is most pronounced in the molecular layer of the cerebellum 
(Figure 6A,B). 
At higher magnification, Eml5 expression can be observed in the granule cells 
of the granule layer, and in Purkinje cells. Because the molecular layer 
receives axonal and dendritic projections from granule cells and Purkinje cells, 
respectively, Eml5 expression appears not to be restricted to either subtype of 
cellular process. Eml5 immunoreactivity can also be observed in the 
hippocampus in all major cell layers and projection areas. 
 
Discussion 
Eml5 primary sequence analysis 
We have isolated and characterized a novel member of the EMAP-like family 
of proteins, Eml5, and two alternative spliced products, Eml5a and Eml5b, both 
of which are C-terminal truncations of Eml5. In humans, three other EML 
proteins have been identified, EML1 (Eudy et al., 1997), EML2 (Lepley et al., 
1999) of which the rat homologue has also been cloned (Ly et al., 2002), and 
EML4/Ropp120 (Heidebrecht et al., 2000). An additional EML, EML3, can be 
predicted from the human genomic sequence. Eml5 is thus far the largest EML 
family member and is the most closely related to the archetypical member, 
EMAP (Figure 1B). 
Interestingly, Eml5 appears to contain a 2.5-fold repeat of the complete EMAP 
protein, as both the N-terminal, middle and C-terminal parts are homologous 
to EMAP. A region that is strongly predicted to form an alpha-helical coiled 
coil, a putative dimerization domain, separates the N-terminal and the middle 
parts. Eml5 may therefore form homodimers or heterodimers with itself or one 
of its splice variants Eml5a or Eml5b. Alternatively, Eml5 may form a 
heterodimer with Eml3 or 4 as these family members also contain a predicted 
dimerization domain. It has been proposed that the microtubule-binding 
domain of EML proteins consists of a highly conserved hydrophobic stretch of 
43 aa, the HELP domain (Eichenmuller et al., 2002). EML proteins do not share 
the microtubule-binding domain of map1a and map1b/map5, the consensus 
being multiple copies of imperfect KKEX repeats (Noble et al., 1989), or of 
other maps like MAP2, Tau and MAP4, the consensus being three to four 
copies of GSX2NX2HXPG3 (Lee et al., 1989). Both N-terminal, middle and C-
terminal parts of Eml5 contain a HELP domain, making Eml5 the only member 
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that contains three such domains. It remains to be determined whether these 
HELP domains actually participate in microtubule binding. 
Eml5 contains, like other EML protein family members, several WD40 domains. 
WD40 repeats are putative protein–protein interaction domains that are 
usually present in 4–16 copies within a single protein (reviewed in Smith et al. 
1999 ). Structurally, these repeats combined form a β propeller. Among the 
broad spectrum of functions of WD40 domain proteins are those involved in 
the regulation of cytoskeletal dynamics like coronin (de Hostos et al., 1991), 
and mitotic spindle formation like CDC40 (Vaisman et al., 1995). Besides the 
above-mentioned features, Eml5 is unique among the EML protein family in 
that it is the only member that lacks a consensus site for an EF hand (for 
review, see Lewit-Bentley and Rety, 2000 ). However, these calcium-binding 
motifs mainly occur in adjacent pairs (Lewit-Bentley and Rety, 2000) and the 
functional significance of a single motif within other EML proteins remains to 
be established. 
 
Cellular functions of Eml proteins 
Both EMAP and EML2 have shown to co-localize with mitotic spindles 
(Eichenmuller et al., 2002; Suprenant et al., 1993). Furthermore, EMAP was 
isolated as the major microtubule-associated protein in dividing sea urchin 
embryos (Suprenant et al., 1993) and EML4/Ropp120 is strongly expressed 
during mitosis (Heidebrecht et al., 2000). These observations suggest that the 
EML family of proteins is a class of MAPs that associate with mitotic spindles of 
dividing cells. Furthermore, both EMAP and EML2 have been reported to 
destabilize microtubules (Eichenmuller et al., 2002; Hamill et al., 1998); EMAP 
increases microtubule dynamics and inhibits the frequency of rescue (the 
transition from shortening to growing microtubules; Hamill et al., 1998) whereas 
EML2 reduces the growth rate and promotes frequency of catastrophes (the 
transition from growing to shortening; Eichenmuller et al., 2002). Although it 
remains to be determined whether Eml5 destabilizes microtubules, a growing 
picture is emerging that the EML protein family is a novel class of microtubule-
destabilizing proteins. Other microtubule-destabilizing proteins include 
Op18/Stathmin and its family members SCG10, SCLIP, RB3 and Katanin, a 
microtubule-severing protein. All of these, like Eml5, are expressed in the 
nervous system (Ahmad et al., 1999; Cassimeris, 2002). 
In the hippocampus, Eml5 mRNA expression is confined to the neuronal layers 
whereas Eml5 immunoreactivity is found in all layers. This suggests that Eml5 
protein is expressed in neuronal processes of the hippocampus. Similarly, in 
the cerebellum, Eml5 immunoreactivity is found over the molecular layer. 
Because both Purkinje cells and granule cells express Eml5, the staining in the 
molecular layer apparently may be derived from both Purkinje cell dendrites 
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and granule cell axons, suggesting that Eml5 regulates microtubule dynamics 
of neuronal processes. Moreover, because Eml5 is expressed during 
development, it may be involved in processes underlying the large-scale 
cytoskeletal rearrangements during neuronal development. As the majority of 
brain regions express Eml5 during development, it can be hypothesized that 
this expression is associated with the increased cytoskeletal dynamics of 
neurons during this time period. It remains to be determined why only a subset 
of brain regions express Eml5 in adult animals but it is tempting to speculate 
that these neurons show an increase in microtubule dynamics when 
compared to non-Eml5 expressing neurons. The granule cells of the dentate 
gyrus are associated with relatively high levels of neurogenesis. This may 
suggest Eml5 expression is related to their mitogenic potential and it will be 
interesting to test this hypothesis using other markers of neurogenesis and 
early neurite expansion. 
In the adult brain, it has been suggested that microtubules can contribute to 
the morphological changes that have been reported in dendritic spines (van 
Rossum and Hanisch, 1999). Dendritic spines are the primary post-synaptic 
targets of excitatory glutamatergic synapses in the mature brain. Recent 
evidence suggests that the microtubule network is linked to the postsynaptic 
density (PSD), a specialized structure below the post-synaptic membrane of 
glutamatergic synapses, via certain scaffold proteins (for review, see van 
Rossum and Hanish, 1999). The PSD contains linker proteins like Cript 
(Niethammer et al., 1998) that associates with both the NMDA receptor 
binding protein PSD95/Sap90 and tubulin. Furthermore, the NMDA receptor 
multiprotein complex associates with both tubulin and Map2B (Husi et al., 
2000). Inhibitory synapses are also associated with the microtubule network 
(for review, see Kneussel and Betz, 2000). For example, the linker protein 
Gephyrin associates with tubulin and binds and localizes GABAA and glycine 
receptors (Kneussel and Betz, 2000). Similarly, the GABAA receptor γ2 and 
GABAc receptor ρ1 subunits interact with GABARAP, a scaffold protein 
containing a tubulin-binding motif (Wang and Olsen, 2000) and MAP1B 
(Hanley et al., 1999), respectively. The presence of tubulin and associated 
proteins within dendritic spines raises the possibility that Eml5 may aid in 
regulating tubulin-related dynamics of dendritic spines. Interestingly, recent 
observations have demonstrated an association between rat-Emap, the rat 
homologue of EML2/huEMAP2, and the synaptic δ2 glutamate receptor (Ly et 
al., 2002) known to be required for the expression of cerebellar long-term 
depression (Kashiwabuchi et al., 1995). The identity of Eml5-associated 
proteins remains to be established. Nevertheless, the broad neuronal 
expression and putative activity of Eml5 and its variants described in this 
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paper highlight their potential significance for neuronal function in the mature 
and developing nervous system. 
 
Conclusions 
We have cloned fifth member of the EML protein family, Eml5, and two 
alternative spliced products splice variants Eml5a and Eml5b, both of which 
are C-terminal truncations of Eml5. Eml5 contains a 2.5-fold repeat of the 
complete EMAP protein, the archetypical member of the EML protein family, 
and is its largest member. Because Eml5 is expressed in post-mitotic neurons 
(in adult animals and during development) and the EML protein family is likely 
to represent a novel class of microtubule destabilizing proteins, we 
hypothesize that Eml5 plays a role in the cytoskeletal rearrangements 
observed during neuronal development and in adult brain.  
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Abstract 
Synaptopodin is an activity dependent, actin-associated protein that is 
localized in the spine neck of telencephalic neurons. Two distinct splice 
variants of Synaptopodin have been described in human and mouse. In this 
study, we have used RT-PCR and in situ hybridisation to determine the 
expression of both splice variants (Synaptopodin I and II) in rat brain (cortex 
and hippocampus) following electrical stimulation. Our results indicate that 
only one Synaptopodin splice variant (rat Synaptopodin II) shows activity 
associated expression. The activity-associated splice variant is distinct from 
human and mouse Synaptopodin II with respect to the 3’ end. Interestingly, 
this activity associated splice variant lacks a domain that, in human 
Synaptopodin, binds to α-actinin and is associated with remodeling of the 
actin cytoskeleton. Although rat Synaptopodin II lacks such a domain, our 
results demonstrate that transient overexpression does induce a marked 
remodeling of the actin cytoskeleton. We next used deletion constructs to 
identify two distinct regions in Synaptopodin II (aa144-489 and aa461-692) 
that are sufficient for colocalization with actin and one region (aa144-489) 
that induces rearrangement of the actin cytoskeleton. Point mutation of two 
PPXY protein-protein interacting domains does not appear to affect 
cytoskeletal remodeling. Our results are suggestive of a causal role of 
Synaptopodin II in the remodeling of the actin cytoskeleton in dendritic spines 
of neurons following electrical stimulation. 
 
Introduction 
Long-term potentiation (LTP) is the strengthening of synaptic efficacy in 
hippocampal and cortical structures (Bliss and Collingridge, 1993). The early 
phase of LTP (E-LTP) lasts up to 6 hours and is not affected by protein and RNA 
synthesis inhibitors. In contrast, the late phase of LTP (L-LTP) can last for hours 
or days and is dependent on de novo RNA and protein synthesis (Bradshaw et 
al., 2003; Frey et al., 1988; Krug et al., 1984; Nguyen et al., 1994; Nguyen and 
Kandel, 1996; Otani et al., 1989). Examples of transcripts that are associated 
with L-LTP, include transcription factors (e.g. Zif268) (Wisden et al., 1990; 
Worley et al., 1993), kinases (Konietzko et al., 1999; Thomas et al., 1994), 
phosphodi-esterases (e.g. PDE10A) (O'Connor et al., 2004a) and cytoskeletal 
proteins (e.g. Homer 1a, Synaptopodin) (Brakeman et al., 1997; Kato et al., 
1997; Matsuo et al., 1998; Yamazaki et al., 2001). As the expression of many of 
these transcripts are necessary for the establishment of L-LTP, functional 
studies of the encoded proteins will help elucidate the underlying molecular 
mechanism of L-LTP.  
Synaptopodin is a gene that is upregulated after the induction of LTP 
(Yamazaki et al., 2001). Similar to other LTP-associated transcripts (Capani et 
Chapter 4 
 
8 0  |  P a g e  
 
al., 2001; Guzowski et al., 2000; Guzowski et al., 1999; Hall et al., 2000; Jones et 
al., 2001; Moita et al., 2002), mice lacking Synaptopodin show a reduced L-LTP 
(Deller et al., 2003). Synaptopodin is expressed in renal podocytes, olfactory 
bulb, cerebral cortex, striatum and hippocampus (Czarnecki et al., 2005; 
Deller et al., 2000a; Mundel et al., 1997). Within neurons, Synaptopodin is 
localized in the neck of mature dendritic spines, where it is associated with F-
actin, α-actinin and the spine apparatus (Deller et al., 2000b). 
Two Synaptopodin splice variant have been described in human and mouse 
(Asanuma et al., 2005; Kremerskothen et al., 2005). These two splice variants 
differ in both their 5’- and 3’-end. As splice variant-specific expression has 
been described for other LTP-associated transcripts (Brakeman et al., 1997; 
Inoue et al., 2004; Kato et al., 1997; O'Connor et al.), we examined such splice 
variant-specific expression in rat Synaptopodin. Our results demonstrate that, 
similar to human Synaptopodin, two Synaptopodin splice variant are 
expressed in rat. Only one of these shows activity-associated expression. 
Because this activity associated splice variant in rat is distinct from human 
Synaptopodin splice variants, we determined its cellular function. 
 
Methods 
All animal experiments were performed in accordance with the 
recommendations by the European Communities Council Directive of 24 
November 1986 (86/609/EEC) and were conducted with the approval of the 
Dutch Ethical Committee for animal experiments. All efforts were made to 
minimize animal suffering. 
 
Electroconvulsive shock (ECS) 
ECS was induced in 4 adult Sprague-Dawley (SD) rats following light 
halothane anaesthesia as described (O'Connor et al., 2004a). In short, ear-
clip electrodes were used to deliver a 200 V (sine wave) at 50 mA for 2 
seconds to induce clonic seizure according to published protocols (Steward, 
1994). Animals were sacrificed 12 hrs post ECS (n = 5 per group). Control rats 
(n = 3) were subjected to equivalent handling without subsequent stimulation. 
All brains were removed, frozen on dry ice and stored at –80 ˚C prior to 
subsequent analysis by in situ hybridisation (French et al., 2001). 
 
In situ hybridization 
In situ hybridizations were performed essentially as described (French et al., 
2001) using 35S radiolabelled oligonucleotides. A 50-fold excess of unlabelled 
oligonucleotide was used as negative control. 45-mer antisense 
oligonucleotides of unique sequence (Invitrogen, Paisley, Scotland) were 
Synaptopodin II is Associated with Activity and Remodels the Actin Cytoskeleton 
 
8 1  |  P a g e  
 
designed against rat sequences that are homologous to exons of human 
Synaptopodin (see supplementary data).  
 
RT-PCR 
Total RNA was isolated from naive adult rat hippocampus or cortex using Trizol 
(Invitrogen) according to manufacturers instructions as described (Houtman 
et al., 2007). 10-15 µg RNA was DNAse treated by adding 2U DNAse (RNAse 
free; Roche), 2 µl transcription buffer and dH2O till a total volume of 20µl and 
15 minutes incubation at 37°C. RNA was precipitated with 100 µl TE, 10 µl 4M 
LiCl and 300 µl ethanol (100%), in the presence of 2 µl glycogen (10 µg/µl), 
washed in 75% ethanol and dissolved in 20 µl TE (RNAse free). RNA samples (1 
µg) were then reverse transcribed for 1 hr at 50°C in the presence of 200U 
Superscript III (Invitrogen), 150 ng oligo dT(18) primer, 0.5 mM dNTP’s, 50 mM 
DTT and RNase inhibitor in a total volume of 20 µl. A control reaction was 
performed in absence of reverse transcriptase; control samples were 
otherwise treated identically. From the reverse transcribed cDNA 0.2 µl was 
used for each RT-PCR reaction. PCR primer pairs are stated in the 
supplementary data. 
 
Constructs 
Full-length Synaptopodin was amplified from rat hippocampal cDNA using 
gene-specific primers 5’-AAAGGGGGGACAAGACAGGC-3’ and 5’-
AAGCACTCCAGCTCCCAAAGCC-3’, sequence verified and cloned into the 
pEGFP-C2 vector (Invitrogen). Synaptopodin gene-fragments were amplified 
on the cloned Synaptopodin construct using the expand high fidelity PCR kit 
(Roche; Basel, Switzerland). For primer sequences see supplementary data 
table 1. All constructs were cloned into pEGFP-C1, pEGFP-C2 or pEGFP-C3 (BD 
Biosciences; Franklin Lakes, NJ). 
 
Transient transfection 
Transient transfections were performed using DEAE-dextran as described 
(O'Connor et al., 2004b). Sixteen hours following transient transfection, cells 
were fixed in ice-cold 4% PFA. Cells were then permeabilized in 0.1% 
Saponin/PBS, blocked in PBS containing 1% BSA, 10% fetal calf serum and 
incubated overnight with a primary antibody mixture. 
 
Antibodies 
The following primary antibodies were used: monoclonal anti-α-actinin 
(mouse IgM; 1:200 (v/v); Sigma), monoclonal anti-α-actinin mouse IgG; 1:200 
and monoclonal anti-synaptopodin mouse IgG; 1:2 (Progen Biotechnik 
GmbH, Heidelberg, Germany). Secondary antibodies were goat-anti-mouse 
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Alexa488, goat-anti-mouse Alexa594, goat-anti-mouse Alexa680 or goat-anti-
mouse IgM (all 1:300; Invitrogen). F-actin was visualized using Alexa Fluor 350 
phalloidin, Alexa Fluor 594 phalloidin or Alexa Fluor 680 phalloidin (1:50; 
Invitrogen). Slides were mounted in Vectashield mounting medium containing 
dapi (Vector laboratories). 
 
Imaging 
Fluorescent images where made using either a Leica (Wetzlar, Germany) 
DMRBE microscope with a 40X oil immersion objective coupled to a 
Hamamatsu (Hamamatsu Photonics K.K.; Hamamatsu City, Japan) C4880 
CCD camera, or using a Zeiss (Jena, Germany) LSM510 confocal laser-
scanning microscope using a 63X oil immersion objective The latter was also 
used to perform live imaging during which cells and objective were kept at 37 
°C, 5% CO2. Images, with an optical slice of ~1 µm, were taken every 10 
minutes for 2 - 6 hours. 
 
Western blot 
Proteins were isolated from transiently transfected Cos7 cells. Isolations were 
performed in ice-cold PBS containing 1% SDS and protease inhibitor cocktail 
(Sigma). Lysed cells were incubated on ice for 20 minutes and centrifuged to 
eliminate protein insoluble fractions. Protein concentrations were measured 
using BCA (Pierce, Perbio Science, The Netherlands) according to the 
manufacturer’s guidelines. Samples diluted in Laemmli sample buffer (LSB; 50 
mM Tris-HCl, pH 6.8, 2.5 % v/v SDS, 12.5% v/v glycerol, 0.01% w/v bromophenol 
blue, 100 mM DTT, β-mercaptoethanol) were denatured for 5 minutes at 95°C, 
after which 20 µg of protein was transferred to 10% acryl-amide gels. 
Following electrophoresis, gels were blotted on nitrocellulose (Bio-rad) using 
Transblot SD semi dry transfer cell (Biorad). The nitrocellulose was blocked in 
TBS containing 5% milk (Nutricia, Cuijk, The Netherlands) and 1% tween. Anti-
GFP (Abcam, Cambridge, UK; 1:5000) was added to the blots in TBS 
containing 2% milk and 1% tween (TBS-T). Next day the blots were washed 
and incubated with secondary antibody (Rabbit-anti-Mouse-HRP, 1:5000 
Dako, Denmark) in TBS-T. The blots were then washed in TBS/1% tween and 
protein signals on the blot were visualized using chemiluminescence 
(Amersham) according to the manufacturer’s instructions. 
 
Results 
Isoform-specific activity-associated regulation of rat Synaptopodin 
Two distinct human splice variants of Synaptopodin have thus far been 
described (accession numbers NM_007286 and AL831818)(Asanuma et al., 
2005). We have plotted the regions on the rat genome that correspond to 
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these human Synaptopodin splice variants. A model of splicing of these 
variants is given in figure 1a. Our first experiments were designed to examine 
which of these isoforms are expressed in naive rat brain (cortex and 
hippocampus). RT-PCR using exon-spanning primers indicated that most 
Synaptopodin exons that are homologous to human Synaptopodin exons are 
expressed in rat brain (figure 1b). However, we failed to find evidence of 
expression for the last exon, exon 5, in 4 independent RT-PCR reactions using 
8-different primer combinations. These exon 5 primers did amplify the correct 
genomic Synaptopodin fragments, confirming their specificity. We did not 
design primers for exon 1, as this exon is not a part of the open reading frame 
of Synaptopodin I. Our experiments indicate that at least two distinct isoforms 
are expressed in adult rat brain. Based on the RT-PCR experiments, we 
suggest that the first isoform (Synaptopodin I) consists of exons 1, 2, 4a and 4b 
whereas the second isoform (Synaptopodin II) is likely to consist of exons 3, 4a 
and 4b. These isoforms are homologues of human Synaptopodin splice 
variants AL831818 and NM_007286 for Synaptopodin I and II respectively. Rat 
Synaptopodin II however differs from human Synaptopodin NM_007286 with 
respect to the 3’ end: rat Synaptopodin II does not contain exon 5 (figure 1a). 
 
It has been demonstrated that Synaptopodin expression is associated with 
activity (Kikuno et al., 1999; Matsuo et al., 1998; Roth et al., 2001; Yamazaki et 
al., 2001). To determine which isoform(s) show activity associated expression, 
we performed in situ hybridization on rat seizure brains using probes that are 
specific for each exon (figure 1C). In situ hybridization indicated that exons 3, 
4a and 4b show activity associated expression whereas exons 1 and 2 do not. 
As Synaptopodin II consists of exons 3, 4a and 4b (see figure 1), these in situ 
hybridization results indicate that Synaptopodin II has an activity associated 
expression in rat hippocampus. Similar to RT-PCR experiments, in situ 
hybridization failed to provide evidence of expression for exon 5. Although no 
quantitative measurements were performed, both our RT-PCR and in situ 
hybridization experiments suggest that Synaptopodin II is expressed at higher 
levels than Synaptopodin I (Figure 1B,C). 
 
Functional role of Synaptopodin II 
Our results demonstrate that Synaptopodin II expression is upregulated 
following electrical activity. However, rat Synaptopodin II lacks a specific 
domain that, in human Synaptopodin is associated with α-actinin and is 
involved in remodeling of the actin cytoskeleton (Asanuma et al., 2005; 
Kremerskothen et al., 2005). Because Synaptopodin II lacks this functional 
domain, we examined the cellular effects of this activity associated isoform.  
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We therefore transiently overexpressed rat Synaptopodin II, N-terminally fused 
to eGFP (GFP-Synaptopodin II) into Cos7 cells. In cells with a relatively low 
GFP-Synaptopodin II expression (based on the relative fluorescence intensity), 
we observed a filamentous staining pattern that colocalizes both with F-actin 
and α-actinin (figure 2B and 3B t=0). In cells with a relatively high expression of 
GFP-Synaptopodin II, we observed GFP-Synaptopodin II aggregates (typical 
aggregates are shown in figure 3B t>90). These aggregates also contain F-
actin and α-actinin (data not shown). No such aggregates were observed 
following transient overexpression of GFP-actin (data not shown). 
Time lapse imaging of GFP-Synaptopodin II demonstrated that Synaptopodin 
filaments, as observed in cells with low GFP-Synaptopodin II expression, 
became shorter and irregular overtime, and eventually formed aggregates 
(figure 2B and figure 3B). In all experiments, a complete colocalisation of F-
actin and GFP-Synaptopodin II was observed (all transfected cells in 4 
independent experiments). Our experiments therefore demonstrate that rat 
Figure 1 Synaptopodin splice variant expression in rat brain (A) Two distinct splice
variants have been described in human: Synaptopodin I (short) consists of exons 1, 2,
4a and 4b; Synaptopodin II (long) consists of exons 3, 4a and 5. In rat, RT-PCR (B) and
in-situ hybridization (C) failed to provide evidence for the expression of exon 5 (B) RT-
PCR demonstrates expression of exons 2-4b but not 5 in rat cortex and hippocampus.
Experiments were run in the presence (+) or absence (-) of reverse transcriptase. (C) In
situ hybridization shows that all exons of splice variant II are up-regulated after activity
(sz: seizure brain, ctr: control brain, C: cortex, H: hippocampus, arrows: startcodon, *:
stopcodon) 
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Synaptopodin II, colocalizes with- and induces remodeling of the actin 
cytoskeleton. 
 
 
 
 
 
 
 
 
 
 
 
 
Domains of Synaptopodin II  involved in actin remodeling 
Although rat Synaptopodin II lacks a domain that, in human Synaptopodin, 
binds to α-actinin, rat Synaptopodin II can still induce remodeling of the actin 
cytoskeleton (figure 2B and figure 3B). We therefore set out to determine 
which region of rat Synaptopodin II is involved in remodeling of the actin 
cytoskeleton. We generated a set of Synaptopodin II deletion constructs that 
were N-terminally fused to GFP (figure 2A) and transiently transfected them 
into Cos7 cells. Cell lysates of transiently transfected cells were used for 
Figure 2 Synaptopodin deletion constructs designed to map regions that colocalize
with F-actin and promote actin aggregate formation (A) Model of Synaptopodin
deletion constructs. Indicated to the right are the levels of F-actin colocalization and
aggregate formation (B) Full length Synaptopodin II (a, h and o) and SP144-489 (e, l and
s) induce and colocalize with actin aggregates. SP314-489 (c, j and q) colocalizes with F-
actin and causes the formation of short filaments. Actin aggregates are never
observed with this construct. SP461-692 (d, h and r) colocalizes with F-actin, induces a
thickening of actin filaments without aggregates being formed. SP144-312 (b, i and p),
SP1-312 (f, m and t) and SP1-505 (g, n and u) colocalize with F-actin but do not affect the
appearance of actin filaments. 
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Western blot and confirmed correct expression of the deletion construct 
(data not shown). 
 
The first 164 amino acids of Synaptopodin II (SP1-164) show even distribution 
throughout the cytoplasm and in the nucleus (data not shown). This fragment 
does not colocalize with F-actin and does not induce remodeling of the actin 
cytoskeleton. SP1-312 does show some degree of filamentous staining that 
colocalizes with F-actin although significant GFP-SP1-312 staining is seen 
throughout the cytoplasm. This cytoplasmic staining may be indicative for a 
relatively low affinity for F-actin. (figure 2B; f, m, t). The actin cytoskeleton has 
normal appearance and therefore SP1-312 does not appear to remodel the 
actin cytoskeleton. Transient overexpression of SP1-505 shows a clear 
filamentous staining pattern that colocalizes with F-actin (figure 2B; g, n, u). 
Similar to the other 3’ Synaptopodin II truncation constructs, SP1-505 does not 
appear to induce actin aggregate formation. 
Our 3’ deletion constructs therefore indicate that remodeling of the actin 
cytoskeleton requires the presence of the last 187 amino acids of 
Synaptopodin II. Indeed, transient overexpression of SP461-692, containing the 
last 231 amino acids of Synaptopodin, shows not only colocalization with F-
actin but F-actin bundles appear thicker and shorter (figure 2B; d, k, r). The last 
231 amino acids are therefore sufficient to associate with F-actin and can 
induce remodeling of actin cytoskeleton. However SP461-692 does not appear 
to induce dramatic remodeling (e.g. formation of aggregates) as observed 
with full-length Synaptopodin II (compare figures 2B, h and 2B, k). Transient 
overexpression of SP144-489 (containing the central region of Synaptopodin II) 
does induce severe actin remodeling (figure 2B; e, l, s, aggregates in cell at 
lower left corner). Similar to full length Synaptopodin II, cells expressing low 
amounts of SP461-692 show a filamentous staining pattern that co-localizes with 
F-actin (2B e, l, s, top cell). 
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Our observations indicate that SP144-489 is sufficient to associate with and 
remodel the actin cytoskeleton (3 independent experiments). The N-terminal 
part of this construct, SP144-312 does colocalize with F-actin but also has a 
relatively high cytoplasmic distribution (figure 2B; b, i, p). This suggests that 
SP144-312 can bind F-actin but with low affinity. In spite of this low affinity, SP144-
312 does induce remodeling of the actin cytoskeleton. Similarly, transient 
overexpression of SP314-489, also shows colocalization with F-actin and a 
relatively high cytoplasmic staining (figure 2B; c, j, q). The actin cytoskeleton 
has a fragmented appearance suggesting this construct can remodel the 
actin cytoskeleton. Although thick, short actin bundles are observed following 
transient transfection with this construct, formation of actin aggregates was 
never observed. This suggests that actin bundling and aggregate formation 
are separate entities. In summary, transient transfection of Synaptopodin 
deletion constructs suggest two regions can associated with actin (amino 
acids 144-489 and 461-692) whereas one central region is involved in 
remodeling of the actin cytoskeleton (amino acids 144-489). 
 
PPXY motifs involved in cytoskeleton remodeling 
The central region of Synaptopodin (SP144-489) that induces remodeling of the 
actin cytoskeleton contains two PPXY protein protein interaction domains. It 
has been hypothesized that these domains are required for remodeling the 
actin cytoskeleton (by recruiting proteins like α-actinin). 
To test whether these domains are indeed involved in cytoskeletal 
remodeling, we generated GFP-Synaptopodin II constructs with point 
mutations in these motifs (SPP312A, SPP331A and SPPP312/331AA). Similar to full length 
Synaptopodin, transient transfection of PPXY mutation constructs showed 
either a filamentous staining pattern that colocalized with F-actin (at low 
Synaptopodin expression levels) or aggregates containing Synaptopodin and 
F-actin (at high Synaptopodin expression levels). Live imaging was used to 
investigate the dynamics of these mutation constructs on the actin 
cytoskeleton. We observed actin remodeling with all constructs, with no gross 
differences with respect to actin aggregate formation. Our findings suggest 
Figure 3 Time lapse imaging of Synaptopodin II with or without point mutations of either or
both PPXY motifs. In all experiments, Synaptopodin II showed complete colocalization with F-
actin (A) Mutation constructs generated: In SPP312A the first PPXY motif (aa 312) is changed to
PATY, in SPP331A the second PPXY motif (aa 331) is changed to PASY. SPPP312/331AA carries both
mutations. (B) Live image showing the formation of Synaptopodin II (and F-actin) aggregates
in a cell expressing Synaptopodin II-GFP (time indicated in minutes). (C) Point mutation in
either or both of the PPXY protein-protein interaction domains do not affect the ability of
Synaptopodin II to remodel the actin cytoskeleton or induce formation of Synaptopodin (and
F-actin) aggregates. Arrows show Synaptopodin II filaments that shorten. 
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that mutation in PPXY motifs do not affect the cytoskeletal remodeling 
capability of Synaptopodin. 
 
Discussion 
Isoform specific expression and regulation 
In this study we have used RT-PCR and in situ hybridization to demonstrate 
that at least two splice variants of Synaptopodin are expressed in rat brain, 
Synaptopodin I and II. One of these isoforms, Synaptopodin II, shows activity 
associated expression. When overexpressed, Synaptopodin II induces 
remodeling of the actin cytoskeleton. 
Rat Synaptopodin I is similar to the human Synaptopodin isoform 
(Synaptopodin short; accession number: AL831818). However, rat 
Synaptopodin II and its human Synaptopodin isoform (Synaptopodin long; 
accession number: NM_007286) differ at the 3’ end: Rat Synaptopodin II and 
human Synaptopodin long contain different 3’ end exons. In rat, 
Synaptopodin I and II splice variants make use of the same 3’ end exon 
whereas in human, Synaptopodin short and long use different 3’ end exons 
(see figure 1). Genomic sequences between human and rat are identical in 
the region surrounding the alternative splice donor site of exon 4 (4a) and the 
splice acceptor site of exon 5. The similarity in primary sequence therefore 
does not explain differences in splice variants between rat and human. It 
remains possible that a splice variant of rat Synaptopodin containing exon 5 is 
expressed in rat kidney, as this tissue was not included in this study. 
Expression of Synaptopodin is associated with electrical activity (Roth et al., 
2001; Yamazaki et al., 2001). Here we demonstrate that Synaptopodin II, and 
not Synaptopodin I, is upregulated after electrical activity. These two rat 
isoforms differ with respect to their 5’ ends suggesting that these two isoforms 
each have a specific promoter. The translational start of Synaptopodin II lies 
within the protein coding region of Synaptopodin I. On the protein level, 
Synaptopodin I therefore contains a unique N-terminus of 245 amino acids. 
This region of includes a leucine zipper and two consensus phoshorylation sites 
(CK2 and PKC). Whether these sites are important for functioning remains to 
be determined. 
 
Colocalization and remodeling of the actin cytoskeleton 
Rat Synaptopodin II lacks a domain that, in human Synaptopodin, can bind 
to α-actinin (Asanuma et al., 2005; Kremerskothen et al., 2005). Our results 
demonstrate that full-length rat Synaptopodin II, similar to human 
Synaptopodin long does show a colocalization with F-actin and α-actinin and 
induces remodeling of the actin cytoskeleton. The actin remodeling function 
of Synaptopodin therefore remains preserved in rat Synaptopodin II. 
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With our deletion constructs we identified two F-actin association domains in 
Synaptopodin II (located within amino acids 144-489 and 461-692) and one 
domain that is required for cytoskeletal remodeling (located within amino 
acids 144-489). Within this remodeling domain, two PPXY motifs are present. 
Mutation of these motifs showed no gross change in actin association and 
remodeling indicating that they are not required for cytoskeletal remodeling. 
There are several ways in which Synaptopodin can affect the dynamics of the 
actin cytoskeleton. First, Synaptopodin can bind directly to actin and so 
affect the dynamics of the cytoskeleton. Alternatively, Synaptopodin can 
associate with several proteins that can induce changes in the actin 
cytoskeleton. For example, Synaptopodin can bind directly to both α-actinin 
and RhoA (Asanuma et al., 2005; Asanuma et al., 2006; Kremerskothen et al., 
2005). 
In brain three isoforms of α-actinin are expressed, namely α-actinin 1, 2 and 4. 
They are abundantly expressed in the post-synaptic density (PSD) (Nakagawa 
et al., 2004; Peng et al., 2004). Where they form a link between NMDA 
receptors and the actin cytoskeleton (Wyszynski et al., 1997). α-actinin 2 is not 
only localized in the PSD, but also shows colocalization with the spine 
apparatus (Wyszynski et al., 1998). Interestingly, Synaptopodin knock-out mice 
lack both a spine apparatus and show a reduced α-actinin 2 expression 
(Asanuma et al., 2005; Deller et al., 2003). 
RhoA is a small GTPase that induces changes in actin cytoskeletal dynamics 
(Ridley, 2006). RhoA is saved from degradation by binding to Synaptopodin 
following which RhoA is activated resulting in the formation of stress fibers 
(Asanuma et al., 2006). RhoA is expressed, in hippocampus (O'Kane et al., 
2003) where activation is associated with a shorter spine neck length (Tashiro 
and Yuste, 2004). 
 
Functional role of Synaptopodin in neurons 
Our results indicate that a distinct splice variant, Synaptopodin II, is 
upregulated following electrical stimulation. In neurons Synaptopodin is 
localized to the neck of mature spines. In spines, actin is the major 
cytoskeletal component (Carlisle and Kennedy, 2005; Fischer et al., 1998). 
Because Synaptopodin II has marked effects on the dynamics of the actin 
cytoskeleton, it is likely that the change in actin dynamics observed following 
electrical activity is mediated, at least partially, through Synaptopodin. 
Several studies indeed show that actin in spines undergoes a rapid turnover 
that is regulated by synaptic activity (Carlisle and Kennedy, 2005; Fischer et 
al., 1998; Star et al., 2002). Activation of the NMDA receptor results in a 
decrease of actin turnover (Carlisle and Kennedy, 2005; Okamoto et al., 2004; 
Star et al., 2002). Synaptopodin is expressed only in mature spines (i.e. those 
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that contain a spine apparatus). As lack of Synaptopodin expression in mouse 
is correlated with a lack of spine apparatus in the spine neck, and therefore a 
lack of mature spines (Deller et al., 2003), upregulation of Synaptopodin II 
following electrical stimulation therefore may be associated with an increase 
in the number of mature spines (Yamazaki et al., 2001). 
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Supplementary Data: 
 
Exon 1 5’-AGCTGGACTCTGCACACACTGGAGAGGAAGTCGGCGGTGCCC-3’ 
Exon 2 5’-ATGGTTGACTCTGCTCTTGCTGGTCCCCTCTTCTTCCAAGTCCAC-3’ 
Exon 3 5’-CCTGGCCGACAAAGAGAGGAAAAATCCCACCTTGACAGTACCCGG-3’ 
Exon 4a 5’-ACTGTGTCTCAGATGAATTTTGTTGGACAGGGGTGATAGTGGCTG-3’ 
Exon 4b 5’-AAGACAGGCACTGGGATGTGTTACTTGAAGCAGAAGGAAGGTTTC-3’ 
Exon 5 5’-CCAAAGCTAAGGGTCAAAGACTACAGTACAGGCTCTTCCTCAGAG-3’ 
Table 1: Exon specific in situ hybridisation probes 
 
 Forward Reverse 
Exon 2 5’-ATGGGACACCACCACTATCCAGAG-3’ 5’-GACGCTGGCTGTCATCACTTTC-3’ 
Exon 3 5’-CAAGGTGGGATTTTTCCTC-3’ 5’-CTCAAAGCCTCTGGAACAG-3’ 
Exon 4a 5’-ACCAGCTTCACAGAAAAGGATCTG-3’ 5’-CTCTTGGCTGAGCTTTGGTGAC-3’ 
Exon 4b 5’-AAGTAACACATCCCAGTGCCTGTC-3’ 5’-TGCCAGACCTTGAACCGTAGAC-3’ 
Exon 5 5’-TAGGCTACAACATCTGTCCTCGGG-3’ 5’-TTCCTTGACCCCCCTTTTCTC-3’ 
Table 2: Exon specific PCR primers 
 
 Forward Reverse 
Exon 2 - 3 5’-ATGGGACACCACCACTATCCAGAG-3’ 5’-CTCAAAGCCTCTGGAACAG-3’ 
Exon 3 – 4a 5’-CAAGGTGGGATTTTTCCTC-3’ 5’-CTCTTGGCTGAGCTTTGGTGAC-3’ 
Exon 4a – 4b 5’-TTCCTTCTCCACCCGGAATG-3’ 5’-ATGGTCCACCTACAGTCACATGC-3’ 
Exon 4b - 5 5’-GGTCCTGCCTCCTGTTCTCAATAC-3’ 5’-CGTTGATGATGTTGCGTGCC-3’ 
Table 3: Interexonal PCR primers 
 
Construct Forward Primer Reverse Primer 
SP 1-164 5’-AAGCACTCCAGCTCCCAAAGCC-3’ 5’-CAATCAGGAGAATGCTGGACCTC-3’ 
SP 1-312 5’-AAGCACTCCAGCTCCCAAAGCC-3’ 5’-GGTGGGGTAAAGTTTCCTAAGGG-3’ 
SP 1-505 5’-AAGCACTCCAGCTCCCAAAGCC-3’ 5’-CGTATTTCTCCATCCGTGACTGG-3’ 
SP 144-
312 
5’-GAGGTCCAGCATTCTCCTGATTG-3’ 5’-GGTGGGGTAAAGTTTCCTAAGGG-3’ 
SP 144-
489 
5’-GAGGTCCAGCATTCTCCTGATTG-3’ 5’-CGTATTTCTCCATCCGTGACTGG-3’ 
SP 314-
489 
5’-CCACCTATGCGGAGACTTTGTC-3’ 5’-CGTATTTCTCCATCCGTGACTGG-3’ 
SP 461-
692 
5’-GCCCAAACCCAACCAGAATC-3’ 5’-
GAAGGTACCACTTGAAGCAGAAGGAAGGTT-
3’ 
SP 
P319A 1 
5’-
CACCAAGCACTCCAGCTCCCAAAGCC-
3’ 
5’-CATAGGTGGCGGGTGGGGTAAAGTTTC-3’ 
SP 
P319A 2 
5’-
TTTACCCCACCCGCCACCTATGCGGAG-
3’ 
5’-AAAGGGGGGACAAGACAGGC-3’ 
SP 
P338A 1 
5’-
CACCAAGCACTCCAGCTCCCAAAGCC-
3’ 
5’-
GTAGAATAAGAGGCAGGAGACCTAACCTGG-
3’ 
SP 
P338A 2 
5’-
GGTTAGGTCTCCTGCCTCTTATTCTACTG-3’ 
5’-AAAGGGGGGACAAGACAGGC-3’ 
Table 4: Primers used for deletion and mutation constructs 
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5.1 Introduction 
Many processes within a cell depend on an intrinsic network of filaments 
called the cytoskeleton. This cytoskeleton is required to determine and 
maintain cell shape, it is required for cell migration, and for intracellular 
transport of proteins and organelles. The cytoskeleton exist of microtubules, 
intermediate filaments and actin filaments (microfilaments). In neurons, 
microtubules are especially important for the delivery of organelles and 
proteins to the periphery, while the actin cytoskeleton is the major 
cytoskeleton component of spines. The cytoskeleton of cells is highly dynamic 
to be able to respond to e.g. migratory stimuli and adapt to changes in the 
environment. Cytoskeletal dynamics is regulated by proteins that associate 
with the cytoskeleton. One of such associated proteins in sea urchins 
(Echinoidea) is the Echinoderm Microtubule Associated Protein (EMAP). EMAP 
is the major microtubule associated protein in sea urchins and several 
mammalian homologs have been identified (Eml1-5). In chapter 2 we have 
characterized one of the mammalian homologs of EMAP, Eml4. In Chapter 3 
we describe the identification of Eml5. Chapter 4 describes a functionally 
characterization study of Synaptopodin, an actin associated protein. Below 
we will discuss the main findings of this thesis. 
 
5.2 Echinoderm Microtubule Associated Protein like proteins. 
Echinoderm microtubule associated protein (EMAP) is the major microtubule 
associated protein (MAP) in dividing sea urchin eggs. Four mammalian 
homologs of EMAP are previously identified, Eml1-4 (Eudy et al., 1997; 
Heidebrecht et al., 2000; Jin et al., 2004; Lepley et al., 1999; Pollmann et al., 
2006; Pozuelo Rubio et al., 2004) whereas a fifth Eml family member, Eml5 is 
described in Chapter 3. 
 
5.2.1 Eml domains and splice variants 
The protein sequences of all five mammalian Emls are highly conserved and 
contain several distinctive domains. All Eml family members contain a 
hydrophobic EMAP like (HELP) domain, a domain that is unique for this family. 
In addition, Emls always contain a coiled coil dimerization domain and 
multiple WD40 protein protein interacting domains (Hamill et al., 1998; Li et al., 
1998; Pollmann et al., 2006; Suprenant et al., 2000). It has been suggested that 
the HELP domain is required for microtubule binding (Eichenmuller et al., 
2002), but in a recent study by Pollmann et al. (2006) the HELP domain of 
Eml4, fused to GFP, failed to colocalize with microtubules. Instead, these 
authors show that the first 249 amino acids of Eml4 are sufficient to bind 
microtubules. The exact function of the HELP domain therefore remains to be 
determined. 
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Protein domain databases (http://pfam.sanger.ac.uk/family?acc=PF03451) 
show a predicted transmembrane helix within the HELP domain. However, no 
localization of any Eml family member to the membrane has been described. 
The presence of a coiled coil in all Eml family members suggests that homo- or 
heterodimers can be formed (Beck and Brodsky, 1998). Whether such dimers 
exist remains to be determined. The third domain present in all Eml family 
members is the WD40 domain. In general, WD40 domains consist of 
approximately 4 to 16 WD repeats. These repeats are 40 amino acids in length 
and often end with a Tryptophan-Aspartic acid (W-D) dipeptide. Each repeat 
forms a blade of a propeller like structure that functions as a protein-protein 
interaction domain. These WD40 domains are present in many proteins of all 
eukaryotes, and are involved in a variety of functions. 
Apart of these domains, Eml1, 2 and 4 contain a single EF hand, a domain 
involved in the binding of calcium. However, EF hands mainly occur in 
adjacent pairs and the functional significance of a single motif remains to be 
established (Lewit-Bentley and Rety, 2000). 
 
 
 
 
In chapter 2 and 3 we show that similar to many other mammalian proteins, 
Eml4 and Eml5 are both alternatively spliced. On protein level, the effect of 
splicing is different for Eml4 and Eml5 (see figure 1). Eml4 splice variants show 
differences in domain structure on the N-terminal whereas, Eml5 splice 
variants (Eml5a and Eml5b) have a premature stopcodon, resulting in 
truncated proteins. Given these results in Eml4 and Eml5 it can be expected 
that other Emls may also undergo alternative splicing. 
 
5.2.2 Eml4 and Eml5 expression 
Following the identification of the domains of the Eml family we investigated 
the spatio-temporal expression of two family members in chapter 2 and 3. Our 
Figure 1 Protein structures of Eml4 and Eml5 splice-variants. 
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results indicate that Eml4 and Eml5 are mainly expressed in the CNS. Eml4 is 
highly expressed during development after which the transcript is down 
regulated (Chapter 2). This developmentally regulated expression suggests 
that Eml4 plays an important role during development. In contrast Eml5 
expression was not detected in early stages of development (Chapter 3). 
Eml5 expression levels increased during development and maintained at high 
levels in hippocampus, cerebellum and olfactory bulb. Non radioactive in situ 
hybridization showed that both Eml4 and Eml5 are expressed in post-mitotic 
neurons. Similar to Eml4 and Eml5, Eml1 is also expressed in the CNS. Other 
regions that express Eml1 include PNS, liver and lung of mouse embryo 
(Blackshaw et al., 2004). Our unpublished results confirm the expression 
pattern of Eml1. To date, no data have been published on the expression of 
Eml2 and Eml3 during development. Our unpublished observations indicate 
that Eml2 expression during development is low and can be observed from 
E15 in mouse in some regions of the mouse. In contrast, the expression of Eml3 
appears to be mainly expressed during development in most regions of the 
mouse. 
As Eml4 and Eml5 are mainly expressed in the CNS we further studied 
postnatal expression of these Emls in young (p10) and adult brain sections. 
Both Eml4 and Eml5 expression is restricted to the olfactory bulb, 
hippocampus and cerebellum in adult brain. 
Interestingly, the expression of other Emls are also mainly restricted to these 
areas: Eml1 in cerebellum, cortex, hippocampus and hindbrain (Blackshaw et 
al., 2004), Eml2 in olfactory bulb, hippocampus, cortex and brainstem, and 
Eml3 is expressed in the hippocampus, thalamus and cerebellum 
(unpublished observations; www.brain-map.org). Our results also indicate that 
on the cellular level Eml1 is expressed in Purkinje cells of the cerebellum 
(unpublished observation). Persistent expression of Emls in the adult brain 
suggests that they are required in post-mitotic neurons. 
The role of Emls during development and in post-mitotic neurons is not know. 
However Eml4 is a microtubule stabilizing protein, which might ensure stable 
microtubules during axonal outgrowth. In the adult brain there is some 
evidence suggesting that Eml proteins can be involved in synaptic plasticity. 
For example Eml2 can bind to the delta2-glutamate receptor (Ly et al., 2002). 
This receptor is only expressed in the cerebellar Purkinje cell, where it is 
required for long-term depression (LTD). Interestingly, the binding site within 
Eml2 for the δ2-glutmate receptor is conserved between the family members 
suggesting that other Emls, like Eml4 or Eml5, may also associate with this 
receptor. Another example is that Eml4 expression is down-regulated following 
nicotine stimulation (Dunckley and Lukas, 2003). The mechanism of Eml 
protein involvement with synaptic plasticity remains to be determined. 
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5.2.3 Microtubule interaction 
We and others have demonstrated that Eml proteins can associate with 
microtubules (Chapter 2, Pollmann et al., 2006). Furthermore, several 
members of the Eml family also affect the dynamics of microtubules. For 
example, Eml2 destabilizes the microtubule cytoskeleton by reducing the 
growth rate and promoting the frequency of catastrophes, while EMAP 
increases the microtubule dynamics and inhibits the frequency of rescue 
(Eichenmuller et al., 2002; Hamill et al., 1998). The results of both Emls is a 
shortening of microtubules. It was therefore hypothesized that the Eml protein 
family destabilizes microtubules. However, in chapter 2 we demonstrate that 
Eml4 does not destabilize the microtubules. In fact, Eml4 increased 
microtubule stability. Because Eml4 was first described as a restrictedly 
overexpressed proliferation-associated protein (Ropp-120) in mitotic cells and 
is highly expressed during development, Eml4 is likely to play a role in the 
stabilization of the microtubule cytoskeleton during cell division. 
Despite the proposed microtubule stabilizing effect of Eml4, the function of 
the other members of the Eml family is not clear yet. The function of Eml1, 
Eml3 and Eml5 still has to be determined. 
 
5.3 Synaptopodin 
Synaptopodin is the founding member of a proline rich protein family. Other 
members of this family are Myopodin and Fesselin. Synapotopodin is 
expressed in renal podocytes, olfactory bulb, cerebral cortex, striatum and 
hippocampus. Myopodin is expressed in skeletal muscle and heart, and 
Fesselin is expressed in avian smooth muscle (Leinweber et al., 1999; Weins et 
al., 2001). With diverse protein domain searching (PFAM, SMART and PROSITE) 
machines no domains could be found in Synaptopodin. However, in 
Myopodin one PDZ domain could be identifies. The protein sequence of 
Fesselin is so far unknown, and mammalian homologs are not described 
(Schroeter and Chalovich, 2005). 
In podocytes, Synaptopodin is involved in cell migration and in the formation 
of stress fibers (Asanuma et al., 2006). In addition, Synaptopodin interacts with 
CD2AP and MAGI-1, thereby linking the cell surface receptors of the split 
diaphragm and the glomerular basement membrane (Faul et al., 2007). This 
tight actin system is needed to form a protein barrier in the kidney. Mice 
lacking Synaptopodin may have proteinuria and/or focal segmental 
glomerulosclerosis (Huber et al., 2006; Yanagida-Asanuma et al., 2007). 
 
5.3.1 Splice variants of Synaptopodin 
Two splice variants of mouse Synaptopodin have been described: 
Synaptopodin long (isoform A; GenBank accession number NP_796314.2) and 
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Synaptopodin short (isoform B; GenBank accession number NP_001103445.1) 
(Asanuma et al., 2005). In chapter 4 we show that, in rat brain, also two 
isoforms of Synaptopodin are also present. Synaptopodin II is the rat homolog 
of Synaptopodin short, while Synaptopodin I appears to be a novel isoform 
(GenBank accession number rat: Q9Z327; mouse: Q8CC35) and consists of 
exon 2, 4a and 4b (figure 2). Both isoforms are expressed in hippocampus and 
cortex, but only Synaptopodin II expression is associated with activity. As 
Synaptopodin I and Synaptopodin II differ in their 5’-end it is likely that each 
variant has its own specific promoter. 
In mice, Synaptopodin long is a splice variant containing exon 5. This isoform is 
reported not to be expressed in mouse brain tissue (Asanuma et al., 2005). 
These observations are in line with our findings, as we were not able to show 
exon 5 expressed in rat brain (Chapter 4). The rat homolog of Synaptopodin 
long therefore does not appear in rat brain, thought it is possible that this 
homolog is expressed in rat kidney. 
 
 
 
 
 
5.3.2 Actin interaction 
In chapter 4 we describe that Synaptopodin II and not Synaptopodin I is 
associated with electrical activation in rat brain. In mice, Synaptopodin long 
has been described to remodel the actin cytoskeleton (Kremerskothen et al., 
2005). However, Synaptopodin long and Synaptopodin II differ in their domain 
architecture as Synaptopodin II does not contain a putative α-actinin binding 
site. We therefore studied the cellular function of rat Synaptopodin II to 
determine whether this isoforms can also remodel the actin cytoskeleton. 
Indeed, overexpression of Synaptopodin II in Cos7 cells, showed a 
colocalization with both F-actin and α-actinin and induces remodeling of the 
actin cytoskeleton. 
To elucidate the functional domains in Synaptopodin II, we generated a series 
of deletion constructs. Our results indicate that two specific regions of 
Synaptopodin II colocalized with F-actin, namely SP144-489 and SP461-692 of 
which SP144-489 also induced remodeling of the actin cytoskeleton. Within 
this domain two PPXY motifs are present. PPXY motifs are putative protein 
interaction domains (Patrie et al., 2002). However, disruption of one or both 
PPXY motifs did not significantly affect the remodeling capacity of 
Figure 2. Three splice variants of Synaptopodin. The arrow is a startcodon, and the * a 
stopcodon. 
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Synaptopodin II. We conclude from this data that these two putative protein 
interaction domains are not necessary for the remodeling capacity of 
Synaptopodin. 
 
5.3.3 Function of Synaptopodin in neurons 
In neurons, Synaptopodin is expressed in the spine neck and the axon initial 
segment. In the spine neck it is associated with the spine apparatus, while in 
the axon initial segment is associates with the cisternal organelle (Bas Orth et 
al., 2007; Deller et al., 2000). Although the cellular function of Synaptopodin in 
neurons is unknown, mice lacking Synaptopodin have a reduced LTP, 
impaired memory formation and spines without a spine apparatus (Deller et 
al., 2003).  
Synaptopodin has a marked effects on the dynamics of the actin 
cytoskeleton, therefore changes in actin dynamics observed following 
electrical activity could be mediated, at least partially, through 
Synaptopodin. Several studies indeed show that actin in spines undergoes a 
rapid turnover that is regulated by synaptic activity (Carlisle and Kennedy, 
2005; Fischer et al., 1998; Star et al., 2002). Upregulation of Synaptopodin II 
following electrical stimulation therefore may be associated with an increase 
in actin dynamics. 
 
5.4 Future plans 
The current thesis presents data on Eml4 and Eml5 expression patterns during 
development and in the mature brain. In addition, we found that Eml4 is a 
microtubule stabilizing protein. Although Emls associate with microtubules and 
modify their dynamics, several key questions remain. These questions involve 
domain architecture and cellular function of Eml proteins. 
The next step in understanding the function of Emls therefore is to investigate 
the interaction of Emls with other proteins. For instance, do the Emls form 
hetero- or homodimers? In what situations and are these dimers functional? 
An overexpression study of constructs without the coiled coil could show the 
functionality of this domain. 
The functional role of the two other domains within Eml proteins, the HELP 
domain and WD40 domains, should also be investigated. First, the conserved 
HELP domain, thought to bind the microtubules, must be required for the 
functioning of Emls. So by using a microtubule binding protein spin-down kit in 
combination with full-length and/or deletion constructs of Eml proteins would 
show whether the HELP domain is required for microtubule binding. 
Second, to understand the function of each Eml, a conditional knock-out 
mouse model will provide good insights. A conditional model should be used 
to prevent compensatory mechanisms, as we have already identified 5 Emls.  
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Third, a more general approach, is using techniques like yeast-2-hybrid, GST-
pull down or biotin-streptavidin pull down assays. These techniques could 
show interaction of full-length Emls, or specific domains (HELP domain or 
WD40 domains) with proteins. The results of these experiments will show a 
functional network for the mammalian Emls. 
To understand the effect of Eml1, 3 and 5 on microtubule dynamics a 
functional analysis should be performed. Such functional analysis can be 
done either by using overexpression studies, equal to described in chapter 2, 
by using RNAi in cells, and/or by in vitro polymerization studies as performed 
using Eml2 and EMAP (Eichenmuller et al., 2002; Hamill et al., 1998). 
Chapter 4 of this thesis describes the function of Synaptopodin II on the 
dynamics of the actin cytoskeleton and the involvement in synaptic plasticity. 
However several questions remain to be answered. For example, what is the 
functional role of Synaptopodin splice variants? This question could be 
answered by 1). using splice variant specific antibodies to determine the 
cellular localization of Synaptopodin I and Synaptopodin II in neurons and 2) 
by generating splice variant specific knock outs to investigate the effect on 
hippocampal LTP and learning. 
The second question that arises, is what are the binding partners of 
Synaptopodin; by using yeast-2-hybrid, GST-pull down or biotin-streptavidin 
pull down assays we could answer which splice variant can bind α-actinin, 
RhoA, MAGI-1 and other proteins that have to be identified. 
Next we would like to investigate the role of Synaptopodin upregulation 
following electrical stimulation. Where are the Synaptopodin proteins 
expressed? And are they only in the spines that have been potentiated? To 
answer this question a combination of bleaching Synaptopodin-GFP, Ca2+ 
imaging and stimulation of cultured hippocampal neurons should be tried. 
The last question that remains to be answered is what the role of 
Synaptopodin is in the axonal initial segment. In the absence of 
Synaptopodin, the cisternal orangelle, which is a Ca2+-storage, is lost. The lost 
of this cisternal organelle may affect the excitability of pyramidal cells 
(Benedeczky et al., 1994). 
 
Together, these experiments could unravel the function and the network of 
both Eml family members and Synaptopodin in neuronal development and 
plasticity. 
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Summary 
 
Many processes within a cell depend on an intrinsic network of filaments 
called the cytoskeleton. The cytoskeleton exists of microtubules, intermediate 
filaments and actin filaments (microfilaments) and is highly dynamic. Both 
microtubule and actin dynamics are regulated by proteins that associate with 
these filaments. In sea urchins, EMAP is the major microtubule associated 
protein and several mammalian homologs have been identified (Eml1-5). 
Chapters 2 and 3 of this thesis focus on Eml4 and Eml5 respectively. Chapter 2 
functionally characterizes Eml4. With in situ hybridization data we show that 
the overall expression of Eml4 decreases during development. However within 
the CNS, PNS, and intestine the expression persists. Furthermore we describe 
that Eml4 expression in the adult brain is restricted to the olfactory bulb, 
hippocampus, and cerebellum. Within these brain areas Eml4 is expressed in 
post-mitotic neurons, e.g. pyramidal cells of the hippocampus and Purkinje 
cells in the cerebellum. Importantly, we are the first to demonstrate that Eml4 
affects microtubule dynamics. In Cos7 cells, we show that overexpression of a 
GFP-tagged Eml4 results in elongated microtubules. Therefore we conclude 
that Eml4 is a microtubules stabilizing protein. 
In Chapter 3 we describe the cloning and characterization of Eml5, a novel 
member of the EMAP protein family. Eml5 differs from other Eml family 
members as it is a 2.5-fold repeat of the complete EMAP protein. With in situ 
hybridization, we show that during development Eml5 expression can be 
observed and expression persist in the adult brain. Here Eml5 is expressed the 
cerebellum (Purkinje cells and granule cells), hippocampus (CA1 pyramidal 
cells and granule cells) and thalamus. 
 
In chapter 4 we focus on Synaptopodin, an actin binding protein, that is 
regulated by neuronal activity. Our results indicate that two splice variants of 
Synaptopodin are expressed in rat hippocampus and cortex, namely 
Synaptopodin I and Synaptopodin II. Interestingly, we show that only one of 
these splice variants, Synaptopodin II, is regulated following electrical 
stimulation. Similar to mouse Synaptopodin, overexpression of full-length rat 
Synaptopodin II induces a clear rearrangement of the actin cytoskeleton. 
Because no known domains are described in Synaptopodin, we generated a 
nested set of deletion constructs to examine functional domains. Our results 
indicate that SP144-489, is sufficient to colocalize and remodel the actin 
cytoskeleton. A second domain SP461-692, is sufficient to colocalize with F-actin 
cytoskeleton but does not induce remodeling. Although, SP144-489, contains 
two putative protein protein interacting domains (PPXY motifs), actin 
association and remodeling still occurs when both motifs are disrupted.  
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In summary, the effect of cytoskeleton associated proteins on the 
cytoskeleton dynamics during development and plasticity help us elucidate 
role of the cytoskeleton during these events. 
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Samenvatting 
 
Elk zoogdier bestaat uit miljoenen cellen. Hoewel deze cellen kunnen 
verschillen in functie is de opbouw van iedere cel vergelijkbaar. Elementen 
zoals de kern, het golgi apparaat, de mitochondrien en het cytoskelet komen 
voor in iedere cel. Het cytoskelet, oftewel skelet van de cel, is nodig om de 
vorm van de cel te behouden en is van belang voor de bewegelijkheid van 
een cel. Ook zorgt het cytoskelet voor het transport in de cel en kan worden 
vergeleken met een “wegennetwerk”. Dit wegennetwerk bestaat uit actine 
filamenten (microfilamenten), intermediaire filamenten en microtubuli. In 
neuronen vormen de microtubuli de “snelwegen” die zorgen voor het 
transport naar alle uithoeken van de cel. Terwijl de actine filamenten zich 
bevinden aan de periferie en vormen daar de “locale wegen”. Het cellulaire 
“wegennetwerk” is zeer dynamisch. Deze dynamiek wordt gereguleerd door 
eiwitten die binden aan de verschillende onderdelen van het netwerk. Om 
deze dynamiek te kunnen begrijpen is het van belang deze cytoskelet 
bindende eiwitten te bestuderen. Dit proefschrift beschrijft twee microtubuli 
bindende eiwitten en het effect dat zij hebben op de dynamiek van 
microtubuli en een actine bindend eiwit. 
 
In hoofdstuk 2 en 3 richten we ons op twee microtubuli bindende eiwitten, 
namelijk Eml4 en Eml5. In hoofdstuk 2 beschrijven we waar Eml4 mRNA tot 
expressie komt, zo laten we met behulp van in situ hybridisatie zien dat Eml4 
expressie gedurende de embryonale ontwikkeling afneemt. Ook laten we 
zien dat ondanks deze afname in specifieke gebieden de expressie van Eml4 
aanwezig blijft (CNS, PNS en darmen). In het volwassen brein komt Eml4 voor 
in niet-delende neuronen van de bulbus olfactorius, hippocampus en 
cerebellum. Aangezien Eml4 tot expressie komt gedurende de ontwikkeling 
en in neuronen speelt Eml4 waarschijnlijk een rol in zowel de ontwikkeling als in 
neuronen. 
Naast de expressie van Eml4 hebben we ook gekeken naar het effect van 
Eml4 op de microtubuli dynamiek. Dit hebben we gedaan door Eml4 te 
fuseren met GFP (groen fluorescerend eiwit) en tot overexpressie te brengen 
in Cos7 cellen. Uit dit experiment bleek dat de microtubuli circulaire structuren 
werden. Hieruit bleek voor het eerst dat Eml4 een microtubuli stabiliserend 
eiwit is. 
In hoofdstuk 3 beschrijven we een nieuw lid van de Eml familie, Eml5. Het 
verschil tussen Eml5 en de andere leden van de familie is dat Eml5 ongeveer 
2,5x de gehele Eml sequentie blijkt te bevatten. Hierdoor zijn domeinen die 
normaal gesproken maar 1 keer voorkomen (bijvoorbeeld het HELP domein), 
nu 3 keer aanwezig. Verder laten we zien dat Eml5 mRNA voorkomt in de 
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granulaire cellen en Purkinje cellen van het cerebellum, de CA1 piramidale 
en granulaire cellen van de hippocampus en in neuronen van de thalamus. 
Hieruit blijkt dat er waarschijnlijk een belangrijke rol voor Eml5 is weggelegd in 
neuronen. 
Verder laten we zien in hoofdstuk 2 en 3 dat zowel Eml4 als Eml5 alternatieve 
splicing ondergaan, waardoor meerdere eiwit isovormen van elke Eml tot 
expressie kunnen komen. 
 
Na heb bestuderen van deze microtubuli bindende eiwitten hebben we ook 
gekeken naar een actine bindend eiwit, Synaptopodin (Hoofdstuk 4). Van dit 
eiwit is al bekend dat het verhoogd tot expressie komt bij specifieke 
activering van neuronen. Bij muizen die geen Synaptopodin tot expressie 
brengen is een vorm van synaptische plasticiteit (LTP) verminderd en ze 
scoren lager in een geheugen test. In hoofdstuk 4 laten we zien dat er in de 
hersenen twee isovormen van Synaptopodin aanwezig zijn (Synaptopodin I 
en Synaptopodin II), waarvan alleen Synaptopodin II verhoogd tot expressie 
komt na neuronale stimulatie. Verder laten we, met behulp van het tot 
overexpressie brengen van Synaptopodin II, zien dat Synaptopodin II 
colocaliseerd met het actine cytoskelet en deze moduleert. Om inzicht te 
krijgen welk gedeelte van Synaptopodin II hiervoor nodig is hebben we 
deletie constructen gemaakt. Deze deletie constructen laten zien dat een 
gedeelte van Synaptopodin, SP144-489, voldoende is om de colocalizeren met 
actine en de dynamiek te veranderen. Een tweede domein, SP461-692, blijkt 
ook te kunnen colocalizeren met actine, maar dit domein heeft geen effect 
op de dynamiek. In het eerste domein, SP144-489, blijken twee eiwit bindende 
motieven te zitten. Echter, de colocalisatie en het effect op de dynamiek 
veranderde niet na het verstoren van deze motieven. 
Uit deze resultaten kan geconcludeerd worden dat na neuronale stimulatie 
Synaptopodin II verhoogd tot expressie komt in neuronen. Door deze 
verhoogde expressie van Synaptopodin zal het actine cytoskelet moduleren, 
en op deze manier zal Synaptopodin II een bijdrage kunnen leveren aan het 
stabiliseren van synaptische contacten. 
 
De resultaten als beschreven in dit proefschrift helpen ons bij het begrijpen 
van het effect van deze cytoskelet bindende eiwitten op de dynamiek van 
het cytoskelet. In het centrale zenuwstelsel zal dit een bijdrage leveren in het 
begrijpen van de rol van het cytoskelet en de dynamiek daarvan gedurende 
de embryonale ontwikkeling en in niet-delende neuronen. Daarnaast levert 
dit proefschrift een bijdrage aan de rol die het cytoskelet speelt in neuronale 
plasticiteit. 
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Curriculum Vitea 
(door Gjalt Reitsma) 
 
Het was op 10 juni 1977 dat Simone Hendrika Houtman werd geboren als 
eerste kind van Jannie en Kees Houtman. Als snel verhuisde de familie 
Houtman naar Dussen, waar Simone haar lagere school deed. 
 
Toen Simone in 1989 naar het Atheneum in Raamsdonkveer ging was zij thuis 
in het gezelschap van een jongere broer en zus. Na een korte overstap naar 
de HAVO heeft Simone haar Atheneum diploma in september 1996 gehaald 
aan het Strabrecht College in Geldrop. Inmiddels was ze ook naar Geldrop 
verhuisd en had ze nog een broer gekregen. Ook had ze Judith leren kennen, 
met wie ze nog steeds veel contact heeft. 
 
Ze moest weer verhuizen toen ze als student Biomedische Wetenschappen 
aan de Universiteit Leiden ging studeren. Als student heeft ze veel plezier 
gehad met haar vrienden Carlijn, Diana, Marissa, Eric en nog vele anderen. In 
diezelfde tijd heeft zij als student-assistent onder leiding van Mark Kruit aan de 
afdeling Radiologie van het Leids Universitair Medisch Centrum gewerkt. Hier 
heeft Simone meegeholpen een databank met genetisch materiaal aan te 
leggen van mensen met migraine. Als stagiair voor Roel Ophof en Arn van de 
Maagdenberg aan de afdeling Humane en Klinische Genetica van de 
Universiteit Leiden heeft zij vervolgens onderzoek gedaan naar de erfelijke 
eigenschappen van migraine met aura. 
 
Een stage waar Simone met veel plezier op terug kijkt was aan de afdeling 
Medische Farmacologie van Ron de Kloet van de Universiteit Leiden. Hier 
heeft zij onderzoek gedaan onder begeleiding van Onno Meijer naar het 
effect van corticosteroïden op transcriptiefactoren in aanwezigheid van co-
factoren. Als afsluitende stage heeft zij onderzoek gedaan naar de expressie 
van een eiwit, GFAP delta, op verschillende plaatsen in de hersenen aan het 
Nederlands Hersen Instituut onder leiding van Reinko Roelofs en Elly Hol. 
 
In 2002 kreeg Simone van Chris de Zeeuw een baan aangeboden als AIO. Ik 
zal mij niet wagen aan een beschrijving van wat zij hier gedaan heeft. Dat 
kan elders in dit proefschrift gevonden worden. 
 
Sinds 1 januari 2006 woont Simone samen met haar vriend. Wij zijn in blijde 
verwachting van een zoon die als alles goed gaat eind juli 2008 geboren zal 
worden. 
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Dankwoord 
 
Nu, na bijna 6 jaar is het zover; mijn promotie is in zicht en de laatste pagina’s 
kunnen geschreven worden. Het dankwoord is een belangrijk onderdeel van 
dit proefschrift, aangezien dit boekje niet tot stand had kunnen komen zonder 
de hulp en steun van vele diverse mensen. 
Als allereerste wil ik Chris, mijn promotor, bedanken. Bedankt voor alle vrijheid 
die je me de afgelopen jaren gegeven hebt. Hierdoor heb ik veel dingen 
geleerd en kunnen doen, zoals basale moleculaire biologie, het opereren en 
injecteren van muizen, gedragsproeven, histologie en uiteindelijk ook 
elektrofysiologie. Je was altijd enthousiast, en er waren altijd leuke proeven te 
doen. Bedankt voor deze dynamische en diverse tijd. 
Pim, ook jij hebt als co-promoter een belangrijke bijdrage geleverd aan dit 
proefschrift. Ik ben (te) makkelijk afgeleid van de hoofdweg. Jij liet me 
afdwalen, maar zorgde dat ik uiteindelijk altijd weer terugkwam op die 
hoofdweg, zodat uiteindelijk toch dat geliefde artikel geschreven kon 
worden. Bedankt voor je eindeloze geduld en dat ik altijd m’n ei bij je kwijt 
kon (privé of werk, dat maakte niet uit). 
Nou Mandy, nu ben jij dan eindelijk aan de beurt. Ik weet dat je liever wat 
hoger had gestaan, maar helaas... Ik wil jou graag bedanken in eerste 
instantie voor alle koffies, theeën en etentjes. Maar natuurlijk ook voor alle 
western blotjes, celkweekjes, muizenbusiness etc. Je bent van een 
gewaardeerde collega een goed vriendin geworden. Wat al wel blijkt uit het 
feit dat men al eerder dacht dat je m’n paranimf zou worden dan dat ik er 
zelf uit was. Maar geloof me ik vind het heel erg fijn dat je naast me staat. 
Voornamelijk de eerste 4 jaar heb ik doorgebracht in Ee1271, het moleculaire 
lab. In het begin veel te ruim voor die paar mensen, maar wel gezellig met 
altijd leuke discussies. Bedankt Phebe, Jenn, Bjorn, Minetta, Hikke, Dmitri, 
Ruben, Eva en Rik. Een speciale dank gaat uit naar Max, je was een leuke en 
gemotiveerde student. Je wilde graag dingen weten die ik voor lief nam 
(zoals hoe het milliQ apparaat werkt) en ik vind het erg leuk dat je AIO bent 
geworden bij Casper. Heel veel succes met jouw boekje! De tweede student 
die ik graag bedank is Sahar, je hebt me geleerd dat het leven niet voor 
iedereen makkelijk is. Ik ben erg blij dat jij en je familie verder kunnen met jullie 
leven in Nederland. Geeske, ook jij verdient een apart stukje, alhoewel je dit 
waarschijnlijk overdreven vind. Ook jij loopt al erg lang rond op de afdeling 
en begon ooit in Ee1271. Je bent een bijzonder mens, en dat is iets heel 
positiefs! Ik vind het altijd erg gezellig om met je kletsen over van alles en nog 
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wat en hoop dat we contact houden. En natuurlijk ook jij heel veel succes 
met je boekje, het dankwoord schrijven is erg leuk! 
Niemand begrijpt een vrouw beter dan een vrouw, we moeten “ventileren”. 
Ook ik heb behoefte hieraan en gelukkig kon ik daarvoor terecht op het 
histo-lab (en natuurlijk ook voor het serieuze werk). Erika en Elize bedankt. Ook 
Loes, Edith en Ria wil ik graag bedanken voor alle gezelligheid, de 
snoepjes/koekjes en natuurlijk ook alle administratieve rompslomp waar jullie 
me mee geholpen hebben. 
Bij de diverse onderzoeken die ik gedaan heb zijn er vele mensen die me 
geholpen hebben. Tom, in het begin van m’n AIO periode heb je me geleerd 
hoe ik injecties kon maken in de olijf en in de cerebellaire kernen. En met veel 
geduld heb je me de daarbij behorende anatomie proberen te leren, 
bedankt voor alle wijze lessen (inclusief die over de anatomie van het hart en 
de longen). Ype, jou wil ik graag bedanken voor de ondersteuning bij het 
fokken en “maken” van muizen. En natuurlijk Dick, bij het gebruiken van 
antilichamen kun je niet om jou heen. Bedankt voor je adviezen over de 
westerns, immuno’s en natuurlijk voor al je humor. Casper, ook met jou heb ik 
heel kort een project gedaan, en ik hoop dat er nog wat met de resultaten 
gedaan wordt, bedankt. 
Het laatste jaar heb ik voornamelijk door gebracht in het Hansel lab. Christian, 
volgens mij duurt het nog wel even voor je een “all-women” lab hebt, maar ik 
wens je heel veel succes in Chicago! Of course to all the (former) members of 
the Hansel lab thanks! Martijn (de R), het was altijd gezellig om met jou op 
een kamer te zitten, hoewel de gesprekken natuurlijk altijd maar over een 
ding gingen... Raghu, it was nice to get to know you, I enjoyed our time 
together on the Hansel lab, and how you learned me to use your set-up. 
Amor, also for you a thank you, especially for the (special) baseball lessons. 
And of course Gen, Boeke and Gao, I would also like to thank you all for 
tolerating my “I hate patching” moods. 
Verder wil ik graag Martijn (S.) bedanken voor de fijne samenwerking en de 
gezellige gesprekken. Freek bedankt voor alle uitleg over electrofysiologie en 
waarom je dingen wel of niet wil corrigeren. En ik hoop dat je mooie 
resultaten boekt met de Nr2b muizen. Rob, Marcel en Tom (S) ook jullie wil ik 
hier graag even noemen. Het was altijd gezellig als ik met jullie derde jaars 
probeerde iets bij te brengen over de anatomie van de mens. Erik, ook jou wil 
ik graag bedanken, altijd gezellig om met je te kletsen als Pim er niet was om 
de telefoon op te nemen. En natuurlijk ook voor alle cellen die je voor me 
klaar hebt gezet! Jos, ook jij bedankt voor de gezellige tijd in de trein (of op 
het station). Hans bedankt voor alle gezellige gesprekken! Eddy, bedankt 
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voor alle ondersteuning met m’n computer en met plaatjes die nog even snel 
afgedrukt moesten worden. Ineke, ook jij bedankt, jouw oplettendheid bij alle 
dingen die ik via AMS aanvroeg heeft mij een hoop tijd en fouten gescheeld. 
Je bent voor al mijn muisproeven onmisbaar geweest. Iemand die ook zeker 
niet vergeten moet worden is Kees, je bent al een tijdje met pensioen, maar ik 
ging altijd met veel plezier naar jouw borrels. Eerst waren die achter de 
klapdeuren, en later beneden. Hier belde de baas dan wel eens naartoe als 
hij vond dat de afdeling wel erg rustig werd voor een vrijdagmiddag. Bedankt 
voor alle bitterballen en biertjes! 
De afdeling Neurowetenschappen kent veel te veel mensen om allemaal te 
kunnen noemen in dit dankwoord. Het voordeel echter van zoveel collega’s 
is dat je onderzoek erg divers is en je veel leert van andere methodes en 
gedachtenwijzes in de maandagochtend werkbesprekingen, hiervoor wil ik 
graag iedereen bedanken. Ik had nooit gedacht zoveel te leren over onder 
andere “grasping”, RSI of whiplashes. 
Naast alle collega’s wil hier graag meteen gebruik maken om een aantal 
bijzondere mensen in mijn leven te bedanken. Te beginnen met twee zeer 
belangrijke mensen in mijn leven. Lieve papa en mama, bedankt voor jullie 
onvoorwaardelijke steun en liefde. Ook het feit dat jullie geen blad voor jullie 
mond nemen is uiteindelijk altijd erg fijn. Jullie hebben mij zeer liefdevol 
opgevoed en daar ben ik jullie (ondanks alle protest in m’n jeugd) nu erg 
dankbaar voor. Sebastiaan, je hebt het als mijn broertje niet altijd makkelijk 
gehad, maar ja ruzie met je maken stond in m’n takenbeschrijving. Je bent 
een schat van een vent en ik wens je heel veel moois en goeds toe. M’n 
enige zusje, Chantelle, je bent heel bijzonder en we lijken helemaal niet op 
elkaar hoor! Ik wens jou heel veel succes toe met KI en ik vind het heel leuk 
dat je me wilt bijstaan bij m’n verdediging. Christiaan, als jongste telg van de 
familie heb je wel wat te verduren, maar je bent er goed tegen bestand. Ik 
vond het erg leuk dat je stage bij me kwam lopen en hoop dat de toekomst 
je veel goeds brengt (je zult er misschien wel hard voor moeten werken 
hoor!). Oma ook u wil ik graag bedanken voor alle steun en gezelligheid.  
Judith, ik ken je al vanaf het Strabrecht College en onze levens hebben er 
sinds die tijd heel anders uitgezien, jij in Maastricht, ik in Leiden en toch heeft 
onze vriendschap altijd stand gehouden. Bedankt voor alle gezellige 
bezoekjes en natuurlijk de geweldige skivakanties! Carlijn, jou ken ik al vanaf 
de El Cid en natuurlijk de Ravenhorst. Bedankt voor alle goede zorgen in die 
lange tijd, we wonen misschien niet meer in dezelfde flat, maar ik vind het erg 
leuk dat we nu allebei in Den Haag wonen. Diana, ook jou wil ik graag 
bedanken voor alle gezellige etentjes en stapavondjes en ik wens jou en Bart 
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9 mei de mooiste dag van jullie leven toe! Marissa, jou wil ik bedanken voor 
alle gezelligheid, etentjes en lunches. Ik wens jou nog veel succes met het 
afronden van jouw boekje, en dan natuurlijk met de opleiding! Caroliene, 
Allard en Jelle ook voor jullie een stukje hier. Jullie ken ik het kortst van 
allemaal, maar dat is ook alweer ruim drie jaar. Bedankt voor alle tosti’s en 
gezelligheid. Jullie staan altijd voor ons klaar en ik verwacht dat dit over 40 
jaar nog steeds zo zal zijn. En ik kan niet wachten tot we gezellig met z’n 
zevenen op vakantie gaan! 
Lieve Piet en Paulien, jullie hebben me drie jaar geleden met veel liefde 
opgenomen in jullie familie. Bedankt hiervoor en natuurlijk ook voor alle 
gezellige avonden, voor de informatie die jullie ons opsturen en alle raad die 
jullie ons geven. Hugo, de eerste keer dat je het vriendinnetje van je broer 
ontmoette vertelde we dat we gingen samenwonen. Het moet voor jou een 
rare gewaarwording zijn geweest, maar je bent een geweldige zwager. 
Gjalt, als laatste wil ik jou graag bedanken. Je bent mijn grote liefde en ik bof 
met jou! Je vind het niet nodig dat ik je noem in dit dankwoord, maar je hebt 
dan zelf niet door hoeveel je voor mij betekent en dus ook hebt betekend 
voor dit boekje. De avondjes samen achter de computer in de Chasséstraat, 
of de lieve woorden als ik er even helemaal doorheen zat. Met andere 
woorden jouw onvoorwaardelijke liefde en steun betekenen heel veel voor 
mij. En ook ik kan niet wachten tot onze zoon er is! Ik heb zoveel zin in de rest 
van ons leven. 
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